
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Global burden of NAFLD 1990–2021 and projections to 2035: Results from the Global Burden of Disease study 2021 - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A2668AF1E83305A266001944D429.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Global burden of NAFLD 1990–2021 and projections to 2035: Results from the Global Burden of Disease study 2021">
<meta name="citation_author" content="Yuqin Mao">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_author" content="Jiqing Du">
<meta name="citation_author_institution" content="School of Life and Health Technology, Dongguan University of Technology, Dongguan, China">
<meta name="citation_author" content="Baoguo Li">
<meta name="citation_author_institution" content="Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical sciences, Zhengzhou University, Zhengzhou, Henan, China">
<meta name="citation_author_institution" content="Innovation Center of Basic Research for Metabolic-Associated Fatty Liver Disease, Ministry of Education of China, Zhengzhou, China">
<meta name="citation_author" content="Jiong Wang">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_author" content="Shaoyan Xuan">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_author" content="Shu Yang">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_author" content="Zhihua Tang">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_author" content="Minxiu Wang">
<meta name="citation_author_institution" content="Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People&#x27;s Republic of China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330504">
<meta name="citation_doi" content="10.1371/journal.pone.0330504">
<meta name="citation_pmid" content="40845036">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/pdf/pone.0330504.pdf">
<meta name="description" content="Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The global burden of NAFLD is increasing. This study used the Global Burden of Disease (GBD) 2021 study data to assess the burden and development trends of NAFLD ...">
<meta name="og:title" content="Global burden of NAFLD 1990–2021 and projections to 2035: Results from the Global Burden of Disease study 2021">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The global burden of NAFLD is increasing. This study used the Global Burden of Disease (GBD) 2021 study data to assess the burden and development trends of NAFLD ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373163">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330504"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330504.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373163%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373163/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373163/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330504" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 22;20(8):e0330504. doi: <a href="https://doi.org/10.1371/journal.pone.0330504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330504</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Global burden of NAFLD 1990–2021 and projections to 2035: Results from the Global Burden of Disease study 2021</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yuqin Mao</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yuqin Mao</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Data curation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuqin Mao</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Du%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jiqing Du</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jiqing Du</span></h3>
<div class="p">
<sup>2</sup>School of Life and Health Technology, Dongguan University of Technology, Dongguan, China</div>
<div>Formal analysis, Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Du%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiqing Du</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Baoguo Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Baoguo Li</span></h3>
<div class="p">
<sup>3</sup>Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical sciences, Zhengzhou University, Zhengzhou, Henan, China</div>
<div class="p">
<sup>4</sup>Innovation Center of Basic Research for Metabolic-Associated Fatty Liver Disease, Ministry of Education of China, Zhengzhou, China</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Baoguo Li</span></a>
</div>
</div>
<sup>3,</sup><sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jiong Wang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jiong Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Formal analysis, Investigation, Resources</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiong Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xuan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shaoyan Xuan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shaoyan Xuan</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Data curation, Formal analysis, Software</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xuan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shaoyan Xuan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shu Yang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shu Yang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shu Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Zhihua Tang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Zhihua Tang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Resources, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhihua Tang</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Minxiu Wang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Minxiu Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div>Data curation, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Minxiu Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Hamidreza Karimi-Sari,</span><sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Pharmacy, Shaoxing People’s Hospital, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, People's Republic of China</div>
<div id="aff002">
<sup>2</sup>School of Life and Health Technology, Dongguan University of Technology, Dongguan, China</div>
<div id="aff003">
<sup>3</sup>Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical sciences, Zhengzhou University, Zhengzhou, Henan, China</div>
<div id="aff004">
<sup>4</sup>Innovation Center of Basic Research for Metabolic-Associated Fatty Liver Disease, Ministry of Education of China, Zhengzhou, China</div>
<div id="edit1">
<sup>5</sup>Johns Hopkins University School of Medicine, UNITED STATES OF AMERICA</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>wmxstu123@163.com</span> (MW); <span>sxtzh@163.com</span> (ZT)</p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>No authors have competing interests.</p></div>
<div class="fn" id="fn001">
<sup>#</sup><p class="display-inline">☯ These authors contributed equally to this work.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Yuqin Mao</span></strong>: <span class="role">Data curation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jiqing Du</span></strong>: <span class="role">Formal analysis, Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Baoguo Li</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jiong Wang</span></strong>: <span class="role">Formal analysis, Investigation, Resources</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shaoyan Xuan</span></strong>: <span class="role">Data curation, Formal analysis, Software</span>
</div>
<div>
<strong class="contrib"><span class="name western">Shu Yang</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zhihua Tang</span></strong>: <span class="role">Resources, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Minxiu Wang</span></strong>: <span class="role">Data curation, Writing – original draft</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Hamidreza Karimi-Sari,</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 14; Accepted 2025 Aug 3; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Mao et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373163  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40845036/" class="usa-link">40845036</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Background</h3>
<p>Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The global burden of NAFLD is increasing. This study used the Global Burden of Disease (GBD) 2021 study data to assess the burden and development trends of NAFLD from 1990 to 2021.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods</h3>
<p>The incidence, prevalence, death and disability-adjusted life years (DALYs) rates of NAFLD in geographic populations worldwide from 1990 to 2021 were extracted from the GBD 2021 study data. The global temporal trend of NAFLD from 1990 to 2021 was evaluated using estimated annual percentage change and age-standardized rate. The Bayesian age-period-cohort model was used to predict NAFLD burden future trends to 2035.</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>The global age standardized incidence rate (ASIR) of NAFLD among the all-age population increased by 25% and the age standardized prevalence rate (ASPR) increased by 24%. The age standardized mortality rate (ASMR) and age standardized DALYs rate (ASDR) were relatively stable. Countries with middle socio-demographic index (SDI) had the highest ASIR and ASPR from 1990 to 2021, high-middle SDI and high SDI had the lowest ASMR and ASDR. North Africa and Middle East had the highest ASIR and ASPR in 2021, ASIR increased at the greatest rate in East Asia and Western Europe, ASPR increased at the greatest rate in Western Europe. In 2021, the highest number of incidence cases and incidence rates were in 20–24 years group, reflecting a tendency towards a younger onset of NAFLD.</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>The global burden of NAFLD has risen steadily from 1990 to 2021, and projections to 2035, placing enormous pressure on society. It is necessary to implement measures targeting risk factors such as high fasting plasma glucose and tobacco, including improving lifestyle, adjusting diet, and applying drug intervention.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Introduction</h2>
<p>Non-alcoholic fatty liver disease (NAFLD), recently rebranded as metabolic-associated fatty liver disease (MAFLD) [<a href="#pone.0330504.ref001" class="usa-link" aria-describedby="pone.0330504.ref001">1</a>], is one of the most common liver diseases in the world [<a href="#pone.0330504.ref002" class="usa-link" aria-describedby="pone.0330504.ref002">2</a>]. According to recent systematic reviews and meta-analyses, the global prevalence of NAFLD has increased from 25.3% in 1990–2006 to 38.0% in 2016–2019 [<a href="#pone.0330504.ref003" class="usa-link" aria-describedby="pone.0330504.ref003">3</a>]. NAFLD comprises a spectrum of disorders typified by an excessive deposition of fat in the liver, excluding alcoholic intake and other identified liver-damaging agents [<a href="#pone.0330504.ref004" class="usa-link" aria-describedby="pone.0330504.ref004">4</a>]. Characterized by an excessive hepatic fat accumulation and accompanied by insulin resistance, it is histologically defined by the presence of steatosis affecting more than 5% of hepatocytes [<a href="#pone.0330504.ref005" class="usa-link" aria-describedby="pone.0330504.ref005">5</a>]. NAFLD encompasses an excessive accumulation of lipids within the liver, leading to lipotoxicity, with potential progression to metabolic-associated steatohepatitis (NASH), liver fibrosis, and hepatocellular carcinoma. It stands as one of the principal causes of hepatocellular carcinoma (HCC) and liver transplantation [<a href="#pone.0330504.ref006" class="usa-link" aria-describedby="pone.0330504.ref006">6</a>].</p>
<p>Extensive epidemiological research has revealed that the pathophysiological ramifications of NAFLD extend beyond the confines of the liver [<a href="#pone.0330504.ref007" class="usa-link" aria-describedby="pone.0330504.ref007">7</a>]. Clinical evidence robustly establishes NAFLD as an independent risk factor for the prevalence and onset of cardiovascular disease (CVD) [<a href="#pone.0330504.ref008" class="usa-link" aria-describedby="pone.0330504.ref008">8</a>–<a href="#pone.0330504.ref010" class="usa-link" aria-describedby="pone.0330504.ref010">10</a>], chronic kidney disease (CKD) [<a href="#pone.0330504.ref011" class="usa-link" aria-describedby="pone.0330504.ref011">11</a>], and type 2 diabetes mellitus (T2DM) [<a href="#pone.0330504.ref012" class="usa-link" aria-describedby="pone.0330504.ref012">12</a>,<a href="#pone.0330504.ref013" class="usa-link" aria-describedby="pone.0330504.ref013">13</a>], thereby elevating the susceptibility to significant extrahepatic chronic illnesses, including CVD, T2DM, and CKD. T2DM and obesity are closely associated with a higher risk of NAFLD. It is estimated that globally, 55–70% of patients with type 2 diabetes have NAFLD, 30–60% have NASH, and 12–20% have clinically significant fibrosis (≥ stage 2) [<a href="#pone.0330504.ref014" class="usa-link" aria-describedby="pone.0330504.ref014">14</a>]. With the rising prevalence of obesity and type 2 diabetes, as well as population aging, the burden of NAFLD is expected to increase in the next decade.</p>
<p>A significant racial disparity is evident in the prevalence of NAFLD, with the highest rates documented in individuals of Latin descent, the lowest in African Americans, and intermediate rates in Caucasians and Asians [<a href="#pone.0330504.ref015" class="usa-link" aria-describedby="pone.0330504.ref015">15</a>]. Analogous to Western countries, the incidence of NAFLD in Asian countries is on the rise, fueled by an increase in cases of obesity, type 2 diabetes, and other components of the metabolic syndrome [<a href="#pone.0330504.ref016" class="usa-link" aria-describedby="pone.0330504.ref016">16</a>,<a href="#pone.0330504.ref017" class="usa-link" aria-describedby="pone.0330504.ref017">17</a>]. As the global obesity epidemic exacerbates metabolic conditions, the clinical and economic toll of NAFLD is set to become staggering [<a href="#pone.0330504.ref015" class="usa-link" aria-describedby="pone.0330504.ref015">15</a>].</p>
<p>Although NAFLD has reached a pandemic proportion globally, no specific pharmacological treatments have been approved for its management [<a href="#pone.0330504.ref018" class="usa-link" aria-describedby="pone.0330504.ref018">18</a>]. While anti-diabetic, lipid-lowering, and natural bile acid therapies have been utilized in the treatment of NAFLD, they are accompanied by certain drawbacks [<a href="#pone.0330504.ref019" class="usa-link" aria-describedby="pone.0330504.ref019">19</a>]. Consequently, the analysis of up-to-date statistical data is crucial for the effective prevention, control, and management of NAFLD. In the present study, we conducted a retrospective examination of the worldwide NAFLD disease burden utilizing data from the Global Burden of Disease (GBD) 2021, thereby providing contemporary estimates for the advancement of ongoing epidemiological research on NAFLD.</p></section><section id="sec006"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">Study data</h3>
<p>This study used data on the incidence, prevalence, deaths and DALYs attributable to NAFLD and the relevant risk factors from 1990 to 2021 obtained from the Global Health Data Exchange (GHDx) query tool (<a href="http://ghdx.healthdata.org/gbd-results-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://ghdx.healthdata.org/gbd-results-tool</a>), based on gender, age, region, and country. The 204 countries and territories were categorized into five levels based on their Socio-Demographic Index (SDl), which includes high, high middle, middle, low middle, and low SDI. SDI was calculated using several social factors, including the fertility rate of the population aged &lt;25 years, the education level of the population aged &gt;15 years, and per capita income [<a href="#pone.0330504.ref020" class="usa-link" aria-describedby="pone.0330504.ref020">20</a>]. According to geographical contiguity, the world was divided geographically into 21 different GBD regions, such as Western Europe and East Asia. The data obtained from the GHDx Query Tool did not require informed patient consent and was publicly available.</p></section><section id="sec008"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>The trends for NAFLD incidence, prevalence, and mortality rates were evaluated by calculating the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), age-standardized DALYs rate (ASDR), and their respective estimated annual percentage change (EAPC). DALYs were computed as the sum of the years lived with disability and the years of life lost. According to the age group construction of the standard population, the ASR (per100, 000 population) were calculated using the following formula:</p>
<table class="disp-formula p" id="pone.0330504.e001"><tr><td class="formula"><math id="M1" display="block" overflow="linebreak"><mrow><mtext>ASR</mtext><mo>=</mo><mfrac><mrow><msubsup><mo>∑</mo><mrow><mi>i</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>A</mi></mrow></msubsup><mspace width="2mu"></mspace><msub><mrow><mi>a</mi></mrow><mrow><mi>i</mi></mrow></msub><msub><mrow><mi>w</mi></mrow><mrow><mi>i</mi></mrow></msub></mrow><mrow><msubsup><mo>∑</mo><mrow><mi>i</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi>A</mi></mrow></msubsup><mspace width="2mu"></mspace><msub><mrow><mi>a</mi></mrow><mrow><mi>i</mi></mrow></msub></mrow></mfrac><mi>×</mi><mn>100</mn><mo>,</mo><mn>000</mn><mo>,</mo></mrow></math></td></tr></table>
<p>(<em>a</em><sub><em>i</em></sub> refers to the incidence of the <em>i</em><sup>th</sup> age group. <em>w</em><sub><em>i</em></sub> denotes the number of persons (or weight) in the same age subgroup <em>i</em> of the assigned reference standard population)</p>
<p>EAPC is used to estimate the trends of the ASRs, and it quantitatively calculates the average annual rate of change of ASR for a specified period [<a href="#pone.0330504.ref021" class="usa-link" aria-describedby="pone.0330504.ref021">21</a>], which follows this formula, i.e., <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pone.0330504.e002"><math id="M2" display="inline" overflow="linebreak"><mrow><mi>y</mi><mo>=</mo><mi>α</mi><mo>+</mo><mi>β</mi><mi>x</mi><mo>+</mo><mi>ε</mi></mrow></math></span>, where <em>y</em> = ln (ASR), and <em>x</em> = the calendar year. The EAPC calculation formula, 100 × (exp(<em>β</em>) − 1), and its 95% confidence intervals (CI) can also be calculated from the linear regression model.</p>
<p>The Bayesian age-period-cohort (BAPC) model can achieve more reasonable predictions to the global burden trends. Based on the assumption that the effects of age, period, and cohort were similar in temporal proximity, Bayesian inference in the BAPC model utilized a second-order stochastic excursion to smooth the prior three aforementioned values and forecast the posterior rates. An integrated nested Laplacian approximation was used with this BAPC model to approximate marginal posterior distributions, avoiding some of the mixing and convergence problems introduced by the Markov Chain Monte Carlo sampling technique traditionally used for Bayesian methods [<a href="#pone.0330504.ref022" class="usa-link" aria-describedby="pone.0330504.ref022">22</a>]. To ensure smoothing, BAPC models assume independent mean-zero normal distributions on the second differences of all effects. Specifically, the BAPC model assumes prior distribution of the age effect as follows:</p>
<table class="disp-formula p" id="pone.0330504.e003"><tr><td class="formula"><math id="M3" display="block" overflow="linebreak"><mrow><mi>f</mi><mrow><mo fence="true" form="prefix" stretchy="true">(</mo><mi>α</mi><mo fence="true" lspace="0.05em" rspace="0.05em" stretchy="true">|</mo><msub><mrow><mi>k</mi></mrow><mrow><mi>α</mi></mrow></msub><mo fence="true" form="postfix" stretchy="true">)</mo></mrow><mo>∝</mo><msubsup><mrow><mi>k</mi></mrow><mrow><mi>α</mi></mrow><mrow><mfrac><mrow><mi>t</mi><mo>−</mo><mtext>2</mtext></mrow><mrow><mtext>2</mtext></mrow></mfrac></mrow></msubsup><mrow><mtext>exp</mtext></mrow><mrow><mo fence="true" form="prefix" stretchy="true">{</mo><mo>−</mo><mfrac><mrow><msub><mrow><mi>k</mi></mrow><mrow><mi>α</mi></mrow></msub></mrow><mrow><mtext>2</mtext></mrow></mfrac><msubsup><mrow><mo>∑</mo></mrow><mrow><mi>i</mi><mo>=</mo><mtext>3</mtext></mrow><mrow><mi>I</mi></mrow></msubsup><msup><mrow><mo fence="true" form="prefix" stretchy="true">[</mo><mrow><mo fence="true" form="prefix" stretchy="true">(</mo><msub><mrow><mi>α</mi></mrow><mrow><mi>i</mi></mrow></msub><mo>−</mo><msub><mrow><mi>α</mi></mrow><mrow><mi>i</mi><mo>−</mo><mtext>1</mtext></mrow></msub><mo fence="true" form="postfix" stretchy="true">)</mo></mrow><mo>−</mo><mrow><mo fence="true" form="prefix" stretchy="true">(</mo><msub><mrow><mi>α</mi></mrow><mrow><mi>i</mi><mo>−</mo><mtext>1</mtext></mrow></msub><mo>−</mo><msub><mrow><mi>α</mi></mrow><mrow><mi>i</mi><mo>−</mo><mtext>2</mtext></mrow></msub><mo fence="true" form="postfix" stretchy="true">)</mo></mrow><mo fence="true" form="postfix" stretchy="true">]</mo></mrow><mrow><mtext>2</mtext></mrow></msup><mo fence="true" form="postfix" stretchy="true">}</mo></mrow><mtext>,</mtext></mrow></math></td></tr></table>
<p>Here, we add an independent random effect <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pone.0330504.e004"><math id="M4" display="inline" overflow="linebreak"><mrow><mtable displaystyle="true" rowspacing="3pt"><mtr><mtd columnalign="right"><msub><mrow><mi>δ</mi></mrow><mrow><mi>a</mi><mo>,</mo><mi>p</mi><mo>+</mo><mi>t</mi></mrow></msub><mi>~</mi><mi>N</mi><mrow><mo fence="true" form="prefix" stretchy="true">(</mo><mtext>0</mtext><mo>,</mo><msubsup><mrow><mi>k</mi></mrow><mrow><mi>δ</mi></mrow><mrow><mo>−</mo><mtext>1</mtext></mrow></msubsup><mo fence="true" form="postfix" stretchy="true">)</mo></mrow></mtd></mtr></mtable></mrow></math></span> to adjust for overdispersion [<a href="#pone.0330504.ref001" class="usa-link" aria-describedby="pone.0330504.ref001">1</a>]. Considering the smoothing assumption, the BAPC models assume prior distribution of the period effect as follows:</p>
<table class="disp-formula p" id="pone.0330504.e005"><tr><td class="formula"><math id="M5" display="block" overflow="linebreak"><mrow><msub><mrow><mi>β</mi></mrow><mrow><mi>p</mi><mo>+</mo><mi>t</mi></mrow></msub><mo stretchy="false">|</mo><msub><mrow><mi>β</mi></mrow><mrow><mtext>1</mtext></mrow></msub><msub><mrow><mtext>,</mtext><mi>…</mi><mtext>,</mtext><mi>β</mi></mrow><mrow><mi>p</mi></mrow></msub><mtext>,</mtext><msub><mrow><mi>k</mi></mrow><mrow><mi>β</mi></mrow></msub><mi>~</mi><mi>N</mi><mo stretchy="false">(</mo><mo stretchy="false">(</mo><mtext>1</mtext><mo>+</mo><mi>t</mi><mo stretchy="false">)</mo><msub><mrow><mi>β</mi></mrow><mrow><mi>p</mi></mrow></msub><mo>−</mo><mi>t</mi><msub><mrow><mi>β</mi></mrow><mrow><mi>p</mi><mo>−</mo><mtext>1</mtext></mrow></msub><mtext>,</mtext><msubsup><mrow><mi>k</mi></mrow><mrow><mi>β</mi></mrow><mrow><mo>−</mo><mtext>1</mtext></mrow></msubsup><mo stretchy="false">(</mo><mtext>1</mtext><mo>+</mo><msup><mrow><mtext>2</mtext></mrow><mrow><mtext>2</mtext></mrow></msup><mo>+</mo><mo>⋯</mo><mo>+</mo><msup><mrow><mi>t</mi></mrow><mrow><mtext>2</mtext></mrow></msup><mo stretchy="false">)</mo><mo stretchy="false">)</mo><mtext>,</mtext></mrow></math></td></tr></table>
<p>The summary estimates (mean, standard deviation, 2.5% quantile, median and 97.5% quantile) of all variance parameters in the BAPC models can be obtained [<a href="#pone.0330504.ref023" class="usa-link" aria-describedby="pone.0330504.ref023">23</a>].</p>
<p>All data analyses were performed using the open-source software R (version 4.3.3). Statistical significance was set at <em>P</em> &lt; 0.05.</p></section></section><section id="sec009"><h2 class="pmc_sec_title">Results</h2>
<section id="sec010"><h3 class="pmc_sec_title">NAFLD burden at global level</h3>
<p>Globally, the incident cases of NAFLD increased by 94% between 1990 and 2021, from 24.86 million to 48.35 million. The age standardized incidence rate (ASIR) of NAFLD among the all-age population increased by 25%, from 475.54 per 100 000 population in 1990 to 593.28 per 100 000 population in 2021, with the estimated annual percentage change (EAPC) was 0.73 (<a href="#pone.0330504.t001" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="pone.0330504.t001"><h4 class="obj_head">Table 1. Incident cases and ASIR of NAFLD in 1990 and 2021, and temporal trends.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">1990</th>
<th align="left" colspan="2" rowspan="1">2021</th>
<th align="left" rowspan="1" colspan="1">1990-2021 EAPC of ASPR (95%CI)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Incident cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASIR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1">Incident cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASIR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Global</strong>
</td>
<td align="left" rowspan="1" colspan="1">24856.16(22579.70-27333.11)</td>
<td align="left" rowspan="1" colspan="1">475.54(432.59-518.19)</td>
<td align="left" rowspan="1" colspan="1">48353.27(44229.14-52358.02)</td>
<td align="left" rowspan="1" colspan="1">593.28(542.72-643.70)</td>
<td align="left" rowspan="1" colspan="1">0.73(0.69-0.77)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Socio-Demographic Index</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">1925.96(1735.02-2127.91)</td>
<td align="left" rowspan="1" colspan="1">483.42(440.22-527.63)</td>
<td align="left" rowspan="1" colspan="1">5396.91(4857.49-5987.67)</td>
<td align="left" rowspan="1" colspan="1">553.74(503.53-605.08)</td>
<td align="left" rowspan="1" colspan="1">0.44(0.41-0.47)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">5235.75(4734.02-5777.13)</td>
<td align="left" rowspan="1" colspan="1">520.74(474.21-566.64)</td>
<td align="left" rowspan="1" colspan="1">12064.46(10980.81-13233.27)</td>
<td align="left" rowspan="1" colspan="1">623.22(569.61-676.22)</td>
<td align="left" rowspan="1" colspan="1">0.59(0.55-0.62)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">9002.61(8141.91-9945.64)</td>
<td align="left" rowspan="1" colspan="1">533.69(485.35-580.65)</td>
<td align="left" rowspan="1" colspan="1">17017.31(15552.70-18416.00)</td>
<td align="left" rowspan="1" colspan="1">656.97(602.08-712.86)</td>
<td align="left" rowspan="1" colspan="1">0.68(0.64-0.72)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">5404.82(4893.94-5906.25)</td>
<td align="left" rowspan="1" colspan="1">478.36(435.28-522.10)</td>
<td align="left" rowspan="1" colspan="1">8509.33(7857.78-9204.00)</td>
<td align="left" rowspan="1" colspan="1">611.29(557.97-665.56)</td>
<td align="left" rowspan="1" colspan="1">0.80(0.71-0.90)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">3262.72(2977.82-3550.60)</td>
<td align="left" rowspan="1" colspan="1">342.72(312.23-373.46)</td>
<td align="left" rowspan="1" colspan="1">5326.14(4910.09-5729.42)</td>
<td align="left" rowspan="1" colspan="1">450.03(412.20-488.43)</td>
<td align="left" rowspan="1" colspan="1">1.00(0.95-1.05)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Region</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Andean Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">171.83(155.69-189.72)</td>
<td align="left" rowspan="1" colspan="1">494.93(453.46-540.75)</td>
<td align="left" rowspan="1" colspan="1">399.22(366.92-433.22)</td>
<td align="left" rowspan="1" colspan="1">582.61(536.86-630.67)</td>
<td align="left" rowspan="1" colspan="1">0.55(0.54-0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Australasia</strong>
</td>
<td align="left" rowspan="1" colspan="1">62.86(56.93-68.90)</td>
<td align="left" rowspan="1" colspan="1">288.08(261.95-315.06)</td>
<td align="left" rowspan="1" colspan="1">117.96(108.10-127.03)</td>
<td align="left" rowspan="1" colspan="1">358.84(328.05-390.77)</td>
<td align="left" rowspan="1" colspan="1">0.72(0.68-0.76)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Caribbean</strong>
</td>
<td align="left" rowspan="1" colspan="1">178.95(162.84-196.25)</td>
<td align="left" rowspan="1" colspan="1">513.74(471.20-559.15)</td>
<td align="left" rowspan="1" colspan="1">287.88(264.11-310.03)</td>
<td align="left" rowspan="1" colspan="1">576.80(528.70-623.41)</td>
<td align="left" rowspan="1" colspan="1">0.42(0.41-0.44)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">347.73(317.65-383.98)</td>
<td align="left" rowspan="1" colspan="1">530.14(485.07-576.45)</td>
<td align="left" rowspan="1" colspan="1">583.56(530.90-636.27)</td>
<td align="left" rowspan="1" colspan="1">612.97(560.97-665.27)</td>
<td align="left" rowspan="1" colspan="1">0.52(0.47-0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">548.34(502.23-593.27)</td>
<td align="left" rowspan="1" colspan="1">419.01(384.12-454.71)</td>
<td align="left" rowspan="1" colspan="1">569.43(525.60-613.24)</td>
<td align="left" rowspan="1" colspan="1">471.53(433.07-510.90)</td>
<td align="left" rowspan="1" colspan="1">0.40(0.38-0.43)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">881.46(800.89-971.67)</td>
<td align="left" rowspan="1" colspan="1">581.20(531.70-632.78)</td>
<td align="left" rowspan="1" colspan="1">1786.20(1641.45-1939.01)</td>
<td align="left" rowspan="1" colspan="1">669.44(615.97-726.19)</td>
<td align="left" rowspan="1" colspan="1">0.48(0.47-0.49)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">193.05(173.26-215.53)</td>
<td align="left" rowspan="1" colspan="1">434.61(395.27-476.05)</td>
<td align="left" rowspan="1" colspan="1">549.88(493.16-610.87)</td>
<td align="left" rowspan="1" colspan="1">469.08(426.91-513.72)</td>
<td align="left" rowspan="1" colspan="1">0.22(0.19-0.26)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>East Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">6397.50(5758.12-7055.94)</td>
<td align="left" rowspan="1" colspan="1">495.87(449.65-540.96)</td>
<td align="left" rowspan="1" colspan="1">9905.42(9094.62-10735.34)</td>
<td align="left" rowspan="1" colspan="1">620.37(565.23-675.90)</td>
<td align="left" rowspan="1" colspan="1">0.73(0.57-0.90)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">1003.38(918.19-1086.54)</td>
<td align="left" rowspan="1" colspan="1">418.62(384.11-454.77)</td>
<td align="left" rowspan="1" colspan="1">1035.05(952.60-1117.15)</td>
<td align="left" rowspan="1" colspan="1">471.81(433.23-511.73)</td>
<td align="left" rowspan="1" colspan="1">0.41(0.37-0.44)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">702.06(625.66-783.55)</td>
<td align="left" rowspan="1" colspan="1">468.64(425.87-512.55)</td>
<td align="left" rowspan="1" colspan="1">1953.11(1744.60-2184.44)</td>
<td align="left" rowspan="1" colspan="1">522.51(475.30-570.84)</td>
<td align="left" rowspan="1" colspan="1">0.36(0.34-0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income Asia Pacific</strong>
</td>
<td align="left" rowspan="1" colspan="1">591.33(539.68-643.48)</td>
<td align="left" rowspan="1" colspan="1">310.56(282.75-338.69)</td>
<td align="left" rowspan="1" colspan="1">728.25(664.40-786.98)</td>
<td align="left" rowspan="1" colspan="1">348.79(319.19-378.61)</td>
<td align="left" rowspan="1" colspan="1">0.53(0.45-0.61)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income North America</strong>
</td>
<td align="left" rowspan="1" colspan="1">974.20(886.65-1063.60)</td>
<td align="left" rowspan="1" colspan="1">321.77(293.45-350.95)</td>
<td align="left" rowspan="1" colspan="1">1635.65(1495.03-1770.49)</td>
<td align="left" rowspan="1" colspan="1">391.24(357.04-425.57)</td>
<td align="left" rowspan="1" colspan="1">0.70(0.68-0.73)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>North Africa and Middle East</strong>
</td>
<td align="left" rowspan="1" colspan="1">2621.74(2382.53-2885.70)</td>
<td align="left" rowspan="1" colspan="1">849.02(777.99-920.82)</td>
<td align="left" rowspan="1" colspan="1">6578.95(6067.96-7080.11)</td>
<td align="left" rowspan="1" colspan="1">1037.64(963.01-1109.65)</td>
<td align="left" rowspan="1" colspan="1">0.70(0.67-0.74)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Oceania</strong>
</td>
<td align="left" rowspan="1" colspan="1">31.40(28.27-34.94)</td>
<td align="left" rowspan="1" colspan="1">542.51(493.89-593.47)</td>
<td align="left" rowspan="1" colspan="1">76.65(69.53-84.51)</td>
<td align="left" rowspan="1" colspan="1">588.57(538.68-640.66)</td>
<td align="left" rowspan="1" colspan="1">0.27(0.23-0.30)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>South Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">4362.69(3921.92-4818.17)</td>
<td align="left" rowspan="1" colspan="1">464.89(421.18-507.16)</td>
<td align="left" rowspan="1" colspan="1">10765.35(9758.06-11817.45)</td>
<td align="left" rowspan="1" colspan="1">564.19(513.27-615.45)</td>
<td align="left" rowspan="1" colspan="1">0.61(0.55-0.67)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southeast Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">2347.04(2125.15-2601.00)</td>
<td align="left" rowspan="1" colspan="1">541.66(491.92-590.09)</td>
<td align="left" rowspan="1" colspan="1">4606.20(4201.35-5033.59)</td>
<td align="left" rowspan="1" colspan="1">622.70(569.31-678.69)</td>
<td align="left" rowspan="1" colspan="1">0.48(0.46-0.50)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">154.12(140.38-168.85)</td>
<td align="left" rowspan="1" colspan="1">313.83(285.65-343.42)</td>
<td align="left" rowspan="1" colspan="1">283.02(258.97-307.04)</td>
<td align="left" rowspan="1" colspan="1">386.42(352.60-420.05)</td>
<td align="left" rowspan="1" colspan="1">0.68(0.64-0.72)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">273.21(245.84-304.04)</td>
<td align="left" rowspan="1" colspan="1">570.40(520.52-622.36)</td>
<td align="left" rowspan="1" colspan="1">532.71(484.10-584.24)</td>
<td align="left" rowspan="1" colspan="1">651.93(597.18-709.27)</td>
<td align="left" rowspan="1" colspan="1">0.47(0.46-0.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Tropical Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">806.67(732.24-888.59)</td>
<td align="left" rowspan="1" colspan="1">557.12(509.05-604.17)</td>
<td align="left" rowspan="1" colspan="1">1584.12(1456.86-1706.17)</td>
<td align="left" rowspan="1" colspan="1">648.83(596.36-700.52)</td>
<td align="left" rowspan="1" colspan="1">0.55(0.53-0.58)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">1387.07(1270.98-1508.21)</td>
<td align="left" rowspan="1" colspan="1">324.92(296.52-354.41)</td>
<td align="left" rowspan="1" colspan="1">1871.64(1719.78-2008.90)</td>
<td align="left" rowspan="1" colspan="1">401.69(368.55-435.70)</td>
<td align="left" rowspan="1" colspan="1">0.73(0.68-0.78)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">818.84(737.07-907.48)</td>
<td align="left" rowspan="1" colspan="1">521.28(474.89-569.13)</td>
<td align="left" rowspan="1" colspan="1">2501.86(2243.38-2767.10)</td>
<td align="left" rowspan="1" colspan="1">597.04(544.27-651.74)</td>
<td align="left" rowspan="1" colspan="1">0.44(0.43-0.45)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330504.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t001fn001"><p><em>ASIR</em> Age-standardized incidence rate, <em>EAPC</em> Estimated annual percentage change, <em>CI</em> Confidence interval, <em>SDI</em> Socio-demographic index, <em>UI</em> Uncertainty interval.</p></div></div></section><p>Similarly, the prevalent cases of NAFLD increased by 125% between 1990 and 2021, from 0.56 billion to 1.27 billion. The age standardized prevalence rate (ASPR) of NAFLD among this age group increased by 24%, from 12085.09 per 100 000 population in 1990 to 15018.07 per 100 000 population in 2021, with the EAPC was 0.73 (<a href="#pone.0330504.t002" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="pone.0330504.t002"><h4 class="obj_head">Table 2. Prevalent cases and ASPR of NAFLD in 1990 and 2021, and temporal trends.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">1990</th>
<th align="left" colspan="2" rowspan="1">2021</th>
<th align="left" rowspan="1" colspan="1">1990-2021 EAPC of ASPR (95%CI)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Prevalent cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASPR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1">Prevalent cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASPR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Global</strong>
</td>
<td align="left" rowspan="1" colspan="1">564432.13(516524.82-618101.25)</td>
<td align="left" rowspan="1" colspan="1">12085.09(11058.41-13184.29)</td>
<td align="left" rowspan="1" colspan="1">1267868.00(1157934.07-1380435.42)</td>
<td align="left" rowspan="1" colspan="1">15018.07(13756.47-16361.44)</td>
<td align="left" rowspan="1" colspan="1">0.73(0.67-0.79)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Socio-Demographic Index</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">40088.81(36552.30-44255.67)</td>
<td align="left" rowspan="1" colspan="1">12421.48(11351.33-13593.54)</td>
<td align="left" rowspan="1" colspan="1">107435.46(98307.36-118879.40)</td>
<td align="left" rowspan="1" colspan="1">13889.22(12685.44-15166.26)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.31-0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">113447.13(103912.27-124978.28)</td>
<td align="left" rowspan="1" colspan="1">13578.98(12385.81-14820.28)</td>
<td align="left" rowspan="1" colspan="1">275895.44(251999.52-301392.88)</td>
<td align="left" rowspan="1" colspan="1">15748.70(14418.61-17126.74)</td>
<td align="left" rowspan="1" colspan="1">0.49(0.44-0.53)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">192822.30(176670.36-212169.96)</td>
<td align="left" rowspan="1" colspan="1">13847.03(12679.85-15124.73)</td>
<td align="left" rowspan="1" colspan="1">453616.04(414597.79-494648.03)</td>
<td align="left" rowspan="1" colspan="1">16589.92(15168.29-18069.08)</td>
<td align="left" rowspan="1" colspan="1">0.61(0.54-0.69)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">131193.56(120116.96-143511.51)</td>
<td align="left" rowspan="1" colspan="1">12230.41(11204.06-13334.14)</td>
<td align="left" rowspan="1" colspan="1">260953.82(239296.77-283534.84)</td>
<td align="left" rowspan="1" colspan="1">15471.06(14155.43-16878.90)</td>
<td align="left" rowspan="1" colspan="1">0.78(0.67-0.89)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">86299.85(79056.14-94042.90)</td>
<td align="left" rowspan="1" colspan="1">8520.08(7809.16-9274.20)</td>
<td align="left" rowspan="1" colspan="1">168913.42(154930.23-182979.40)</td>
<td align="left" rowspan="1" colspan="1">11543.68(10585.57-12529.08)</td>
<td align="left" rowspan="1" colspan="1">1.09(1.04-1.14)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Region</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Andean Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">3550.47(3245.58-3891.05)</td>
<td align="left" rowspan="1" colspan="1">12946.17(11857.20-14128.82)</td>
<td align="left" rowspan="1" colspan="1">9737.66(8884.04-10649.71)</td>
<td align="left" rowspan="1" colspan="1">14984.76(13708.36-16361.47)</td>
<td align="left" rowspan="1" colspan="1">0.53(0.51-0.55)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Australasia</strong>
</td>
<td align="left" rowspan="1" colspan="1">1656.06(1512.94-1804.38)</td>
<td align="left" rowspan="1" colspan="1">7376.03(6738.42-8024.72)</td>
<td align="left" rowspan="1" colspan="1">3778.62(3457.86-4124.39)</td>
<td align="left" rowspan="1" colspan="1">9468.25(8665.51-10349.36)</td>
<td align="left" rowspan="1" colspan="1">0.83(0.80-0.87)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Caribbean</strong>
</td>
<td align="left" rowspan="1" colspan="1">4233.44(3871.41-4631.11)</td>
<td align="left" rowspan="1" colspan="1">14073.50(12862.57-15354.69)</td>
<td align="left" rowspan="1" colspan="1">8111.96(7440.86-8804.73)</td>
<td align="left" rowspan="1" colspan="1">15650.72(14340.15-16986.20)</td>
<td align="left" rowspan="1" colspan="1">0.38(0.37-0.40)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">7937.27(7270.98-8700.39)</td>
<td align="left" rowspan="1" colspan="1">14118.98(12962.74-15421.66)</td>
<td align="left" rowspan="1" colspan="1">15204.17(13885.52-16673.76)</td>
<td align="left" rowspan="1" colspan="1">16120.05(14735.29-17604.48)</td>
<td align="left" rowspan="1" colspan="1">0.45(0.41-0.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">15977.95(14560.92-17364.34)</td>
<td align="left" rowspan="1" colspan="1">11366.94(10414.56-12359.43)</td>
<td align="left" rowspan="1" colspan="1">20606.02(18822.10-22372.11)</td>
<td align="left" rowspan="1" colspan="1">12731.47(11618.63-13852.64)</td>
<td align="left" rowspan="1" colspan="1">0.39(0.37-0.41)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">17471.42(16058.56-19196.19)</td>
<td align="left" rowspan="1" colspan="1">14960.34(13710.10-16309.99)</td>
<td align="left" rowspan="1" colspan="1">44693.57(40900.17-48782.24)</td>
<td align="left" rowspan="1" colspan="1">16983.98(15536.52-18533.59)</td>
<td align="left" rowspan="1" colspan="1">0.44(0.43-0.45)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">3761.67(3403.64-4187.89)</td>
<td align="left" rowspan="1" colspan="1">10904.86(9951.55-12009.31)</td>
<td align="left" rowspan="1" colspan="1">10850.62(9833.00-11986.28)</td>
<td align="left" rowspan="1" colspan="1">11870.63(10844.86-12943.36)</td>
<td align="left" rowspan="1" colspan="1">0.28(0.25-0.32)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>East Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">142094.26(129881.12-156713.75)</td>
<td align="left" rowspan="1" colspan="1">12789.93(11676.75-14020.27)</td>
<td align="left" rowspan="1" colspan="1">301408.39(274406.34-328824.04)</td>
<td align="left" rowspan="1" colspan="1">15596.18(14262.43-16999.34)</td>
<td align="left" rowspan="1" colspan="1">0.67(0.45-0.90)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">28935.07(26460.11-31524.21)</td>
<td align="left" rowspan="1" colspan="1">11080.88(10133.33-12074.69)</td>
<td align="left" rowspan="1" colspan="1">34696.29(31695.85-37763.37)</td>
<td align="left" rowspan="1" colspan="1">12293.91(11254.47-13359.17)</td>
<td align="left" rowspan="1" colspan="1">0.32(0.31-0.33)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">13521.29(12352.29-14926.69)</td>
<td align="left" rowspan="1" colspan="1">11774.95(10738.60-12873.14)</td>
<td align="left" rowspan="1" colspan="1">37304.08(34041.06-41466.67)</td>
<td align="left" rowspan="1" colspan="1">13162.12(12037.13-14400.23)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.33-0.37)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income Asia Pacific</strong>
</td>
<td align="left" rowspan="1" colspan="1">15202.61(13914.42-16576.61)</td>
<td align="left" rowspan="1" colspan="1">7690.99(7025.96-8379.61)</td>
<td align="left" rowspan="1" colspan="1">24694.24(22636.60-26784.25)</td>
<td align="left" rowspan="1" colspan="1">8885.73(8148.40-9666.66)</td>
<td align="left" rowspan="1" colspan="1">0.58(0.51-0.65)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income North America</strong>
</td>
<td align="left" rowspan="1" colspan="1">25568.85(23386.40-27948.79)</td>
<td align="left" rowspan="1" colspan="1">7946.82(7253.21-8661.46)</td>
<td align="left" rowspan="1" colspan="1">48995.59(44673.05-53423.29)</td>
<td align="left" rowspan="1" colspan="1">10056.02(9187.35-10925.56)</td>
<td align="left" rowspan="1" colspan="1">0.89(0.85-0.93)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>North Africa and Middle East</strong>
</td>
<td align="left" rowspan="1" colspan="1">52713.32(48290.12-57887.15)</td>
<td align="left" rowspan="1" colspan="1">21902.49(20094.34-23849.75)</td>
<td align="left" rowspan="1" colspan="1">164312.59(151441.88-179050.65)</td>
<td align="left" rowspan="1" colspan="1">27686.69(25586.92-29914.62)</td>
<td align="left" rowspan="1" colspan="1">0.82(0.77-0.87)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Oceania</strong>
</td>
<td align="left" rowspan="1" colspan="1">605.23(551.74-670.03)</td>
<td align="left" rowspan="1" colspan="1">13706.50(12511.17-15026.99)</td>
<td align="left" rowspan="1" colspan="1">1625.69(1483.82-1796.52)</td>
<td align="left" rowspan="1" colspan="1">15182.69(13936.16-16584.71)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.32-0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>South Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">99245.06(90560.95-109619.91)</td>
<td align="left" rowspan="1" colspan="1">12361.12(11282.78-13532.19)</td>
<td align="left" rowspan="1" colspan="1">249790.70(227865.12-273237.52)</td>
<td align="left" rowspan="1" colspan="1">14158.33(12940.87-15445.08)</td>
<td align="left" rowspan="1" colspan="1">0.43(0.34-0.51)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southeast Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">49379.73(45181.58-54280.55)</td>
<td align="left" rowspan="1" colspan="1">13984.92(12785.15-15266.89)</td>
<td align="left" rowspan="1" colspan="1">115103.79(104841.85-125940.61)</td>
<td align="left" rowspan="1" colspan="1">15691.67(14308.28-17127.24)</td>
<td align="left" rowspan="1" colspan="1">0.39(0.38-0.41)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">3801.55(3476.77-4182.35)</td>
<td align="left" rowspan="1" colspan="1">7995.98(7321.85-8783.11)</td>
<td align="left" rowspan="1" colspan="1">8080.74(7374.98-8823.03)</td>
<td align="left" rowspan="1" colspan="1">10292.48(9394.62-11265.42)</td>
<td align="left" rowspan="1" colspan="1">0.84(0.80-0.89)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">5251.57(4811.69-5773.20)</td>
<td align="left" rowspan="1" colspan="1">13932.66(12701.43-15196.92)</td>
<td align="left" rowspan="1" colspan="1">11781.79(10763.17-12907.45)</td>
<td align="left" rowspan="1" colspan="1">15937.24(14572.60-17388.03)</td>
<td align="left" rowspan="1" colspan="1">0.43(0.41-0.46)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Tropical Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">18156.84(16647.04-20103.25)</td>
<td align="left" rowspan="1" colspan="1">15001.90(13772.66-16413.10)</td>
<td align="left" rowspan="1" colspan="1">42870.51(39161.07-46852.27)</td>
<td align="left" rowspan="1" colspan="1">16662.75(15244.95-18205.46)</td>
<td align="left" rowspan="1" colspan="1">0.39(0.37-0.40)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">38629.11(35378.10-41988.28)</td>
<td align="left" rowspan="1" colspan="1">8144.98(7490.53-8873.81)</td>
<td align="left" rowspan="1" colspan="1">66258.94(60940.04-71561.63)</td>
<td align="left" rowspan="1" colspan="1">10841.79(9939.03-11801.96)</td>
<td align="left" rowspan="1" colspan="1">0.98(0.93-1.03)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">16739.35(15345.72-18454.59)</td>
<td align="left" rowspan="1" colspan="1">13317.94(12164.76-14554.97)</td>
<td align="left" rowspan="1" colspan="1">47962.04(43856.19-53002.94)</td>
<td align="left" rowspan="1" colspan="1">14936.85(13659.28-16347.60)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.33-0.36)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330504.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t002fn001"><p><em>ASIR</em> Age-standardized prevalence rate, <em>EAPC</em> Estimated annual percentage change, <em>CI</em> Confidence interval, <em>SDI</em> Socio-demographic index, <em>UI</em> Uncertainty interval.</p></div></div></section><p>The death cases and DALYs of NAFLD also increased between 1990 and 2021. Death cases increased from 59.54 thousand to 138.33 thousand, with DALYs increased from 1689.25 thousand to 3667.27 thousand. However, the age standardized mortality rate (ASMR) and age standardized DALYs rate (ASDR) had no obvious changes. ASMR changed from 1.53 per 100 000 population in 1990 to 1.62 per 100 000 population in 2021. ASDR changed from 40.20 per 100 000 population in 1990 to 42.40 per 100 000 population in 2021. (<a href="#pone.0330504.t003" class="usa-link">Tables 3</a> and <a href="#pone.0330504.t004" class="usa-link">4</a>).</p>
<section class="tw xbox font-sm" id="pone.0330504.t003"><h4 class="obj_head">Table 3. Death cases and ASMR of NAFLD in 1990 and 2021, and temporal trends.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">1990</th>
<th align="left" colspan="2" rowspan="1">2021</th>
<th align="left" rowspan="1" colspan="1">1990-2021 EAPC of ASMR (95%CI)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Death cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASMR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1">Death cases, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASMR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Global</strong>
</td>
<td align="left" rowspan="1" colspan="1">59.54(45.67-76.30)</td>
<td align="left" rowspan="1" colspan="1">1.53(1.17-1.97)</td>
<td align="left" rowspan="1" colspan="1">138.33(108.29-173.90)</td>
<td align="left" rowspan="1" colspan="1">1.62(1.27-2.02)</td>
<td align="left" rowspan="1" colspan="1">0.19(0.14-0.24)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Socio-Demographic Index</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">4.03(2.91-5.55)</td>
<td align="left" rowspan="1" colspan="1">1.89(1.34-2.67)</td>
<td align="left" rowspan="1" colspan="1">8.41(6.56-10.87)</td>
<td align="left" rowspan="1" colspan="1">1.74(1.34-2.23)</td>
<td align="left" rowspan="1" colspan="1">−0.32(−0.36--0.28)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">9.65(6.96-13.47)</td>
<td align="left" rowspan="1" colspan="1">1.69(1.20-2.43)</td>
<td align="left" rowspan="1" colspan="1">26.19(19.44-33.98)</td>
<td align="left" rowspan="1" colspan="1">1.87(1.39-2.41)</td>
<td align="left" rowspan="1" colspan="1">0.37(0.35-0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">16.08(12.37-20.44)</td>
<td align="left" rowspan="1" colspan="1">1.63(1.25-2.11)</td>
<td align="left" rowspan="1" colspan="1">46.55(36.62-58.52)</td>
<td align="left" rowspan="1" colspan="1">1.78(1.39-2.21)</td>
<td align="left" rowspan="1" colspan="1">0.36(0.33-0.40)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">14.18(10.78-18.10)</td>
<td align="left" rowspan="1" colspan="1">1.47(1.12-1.86)</td>
<td align="left" rowspan="1" colspan="1">27.01(20.90-34.20)</td>
<td align="left" rowspan="1" colspan="1">1.40(1.09-1.76)</td>
<td align="left" rowspan="1" colspan="1">−0.14(−0.30-0.01)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">15.52(11.78-20.04)</td>
<td align="left" rowspan="1" colspan="1">1.43(1.09-1.84)</td>
<td align="left" rowspan="1" colspan="1">30.01(23.14-37.48)</td>
<td align="left" rowspan="1" colspan="1">1.48(1.15-1.85)</td>
<td align="left" rowspan="1" colspan="1">0.13(0.05-0.22)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Region</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Andean Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.97(0.68-1.33)</td>
<td align="left" rowspan="1" colspan="1">4.73(3.32-6.45)</td>
<td align="left" rowspan="1" colspan="1">3.44(2.36-4.73)</td>
<td align="left" rowspan="1" colspan="1">5.89(4.03-8.07)</td>
<td align="left" rowspan="1" colspan="1">0.71(0.62-0.80)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Australasia</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.18(0.14-0.23)</td>
<td align="left" rowspan="1" colspan="1">0.78(0.60-1.01)</td>
<td align="left" rowspan="1" colspan="1">0.66(0.52-0.81)</td>
<td align="left" rowspan="1" colspan="1">1.27(1.01-1.55)</td>
<td align="left" rowspan="1" colspan="1">1.77(1.63-1.91)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Caribbean</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.72(0.52-0.96)</td>
<td align="left" rowspan="1" colspan="1">2.82(2.04-3.72)</td>
<td align="left" rowspan="1" colspan="1">1.60(1.13-2.20)</td>
<td align="left" rowspan="1" colspan="1">2.97(2.11-4.07)</td>
<td align="left" rowspan="1" colspan="1">0.13(−0.13-0.38)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">1.01(0.75-1.33)</td>
<td align="left" rowspan="1" colspan="1">2.17(1.60-2.86)</td>
<td align="left" rowspan="1" colspan="1">2.75(1.99-3.73)</td>
<td align="left" rowspan="1" colspan="1">3.41(2.47-4.59)</td>
<td align="left" rowspan="1" colspan="1">1.66(1.42-1.89)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">2.02(1.50-2.69)</td>
<td align="left" rowspan="1" colspan="1">1.37(1.02-1.79)</td>
<td align="left" rowspan="1" colspan="1">3.50(2.57-4.72)</td>
<td align="left" rowspan="1" colspan="1">1.69(1.24-2.27)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.19-0.51)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">3.59(2.59-4.76)</td>
<td align="left" rowspan="1" colspan="1">4.21(3.04-5.56)</td>
<td align="left" rowspan="1" colspan="1">12.63(9.45-16.29)</td>
<td align="left" rowspan="1" colspan="1">5.00(3.74-6.45)</td>
<td align="left" rowspan="1" colspan="1">0.56(0.48-0.63)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.40(0.26-0.63)</td>
<td align="left" rowspan="1" colspan="1">1.76(1.14-2.85)</td>
<td align="left" rowspan="1" colspan="1">0.91(0.59-1.38)</td>
<td align="left" rowspan="1" colspan="1">1.61(1.04-2.50)</td>
<td align="left" rowspan="1" colspan="1">−0.41(−0.50--0.33)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>East Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">8.69(6.74-10.95)</td>
<td align="left" rowspan="1" colspan="1">1.04(0.80-1.32)</td>
<td align="left" rowspan="1" colspan="1">17.60(13.57-21.98)</td>
<td align="left" rowspan="1" colspan="1">0.83(0.65-1.04)</td>
<td align="left" rowspan="1" colspan="1">−0.54(−0.66--0.41)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">2.55(1.87-3.42)</td>
<td align="left" rowspan="1" colspan="1">0.92(0.68-1.22)</td>
<td align="left" rowspan="1" colspan="1">8.42(6.16-11.40)</td>
<td align="left" rowspan="1" colspan="1">2.66(1.93-3.62)</td>
<td align="left" rowspan="1" colspan="1">3.58(2.92-4.25)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">1.59(1.19-2.11)</td>
<td align="left" rowspan="1" colspan="1">2.28(1.68-3.04)</td>
<td align="left" rowspan="1" colspan="1">3.81(2.86-5.04)</td>
<td align="left" rowspan="1" colspan="1">2.40(1.79-3.19)</td>
<td align="left" rowspan="1" colspan="1">0.04(−0.02-0.09)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income Asia Pacific</strong>
</td>
<td align="left" rowspan="1" colspan="1">3.10(2.44-3.82)</td>
<td align="left" rowspan="1" colspan="1">1.57(1.24-1.94)</td>
<td align="left" rowspan="1" colspan="1">4.55(3.41-5.71)</td>
<td align="left" rowspan="1" colspan="1">0.87(0.67-1.08)</td>
<td align="left" rowspan="1" colspan="1">−2.09(−2.24--1.94)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income North America</strong>
</td>
<td align="left" rowspan="1" colspan="1">3.67(2.80-4.72)</td>
<td align="left" rowspan="1" colspan="1">1.07(0.82-1.40)</td>
<td align="left" rowspan="1" colspan="1">9.82(7.58-12.38)</td>
<td align="left" rowspan="1" colspan="1">1.56(1.21-1.97)</td>
<td align="left" rowspan="1" colspan="1">1.44(1.29-1.59)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>North Africa and Middle East</strong>
</td>
<td align="left" rowspan="1" colspan="1">3.68(2.50-5.49)</td>
<td align="left" rowspan="1" colspan="1">2.64(1.74-4.06)</td>
<td align="left" rowspan="1" colspan="1">11.00(8.02-14.95)</td>
<td align="left" rowspan="1" colspan="1">2.70(1.93-3.68)</td>
<td align="left" rowspan="1" colspan="1">0.10(0.02-0.18)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Oceania</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.03(0.02-0.04)</td>
<td align="left" rowspan="1" colspan="1">0.89(0.58-1.48)</td>
<td align="left" rowspan="1" colspan="1">0.06(0.04-0.09)</td>
<td align="left" rowspan="1" colspan="1">0.81(0.57-1.13)</td>
<td align="left" rowspan="1" colspan="1">−0.52(−0.64--0.41)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>South Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">6.43(4.55-9.11)</td>
<td align="left" rowspan="1" colspan="1">1.10(0.77-1.57)</td>
<td align="left" rowspan="1" colspan="1">18.67(13.61-24.92)</td>
<td align="left" rowspan="1" colspan="1">1.30(0.93-1.73)</td>
<td align="left" rowspan="1" colspan="1">0.51(0.45-0.56)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southeast Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">4.01(2.89-5.74)</td>
<td align="left" rowspan="1" colspan="1">1.62(1.15-2.40)</td>
<td align="left" rowspan="1" colspan="1">11.50(8.41-15.01)</td>
<td align="left" rowspan="1" colspan="1">1.86(1.35-2.40)</td>
<td align="left" rowspan="1" colspan="1">0.46(0.39-0.54)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.82(0.57-1.12)</td>
<td align="left" rowspan="1" colspan="1">1.79(1.24-2.44)</td>
<td align="left" rowspan="1" colspan="1">1.48(1.07-1.99)</td>
<td align="left" rowspan="1" colspan="1">1.70(1.23-2.29)</td>
<td align="left" rowspan="1" colspan="1">0.26(0.13-0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.50(0.36-0.71)</td>
<td align="left" rowspan="1" colspan="1">1.84(1.29-2.66)</td>
<td align="left" rowspan="1" colspan="1">1.58(1.25-1.98)</td>
<td align="left" rowspan="1" colspan="1">2.80(2.21-3.48)</td>
<td align="left" rowspan="1" colspan="1">1.16(0.70-1.63)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Tropical Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">1.13(0.84-1.49)</td>
<td align="left" rowspan="1" colspan="1">1.18(0.89-1.55)</td>
<td align="left" rowspan="1" colspan="1">3.57(2.68-4.59)</td>
<td align="left" rowspan="1" colspan="1">1.38(1.04-1.77)</td>
<td align="left" rowspan="1" colspan="1">0.76(0.66-0.87)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">12.18(8.87-15.75)</td>
<td align="left" rowspan="1" colspan="1">2.17(1.60-2.80)</td>
<td align="left" rowspan="1" colspan="1">15.69(11.84-19.57)</td>
<td align="left" rowspan="1" colspan="1">1.75(1.34-2.20)</td>
<td align="left" rowspan="1" colspan="1">−0.75(−0.90--0.59)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">2.28(1.55-3.45)</td>
<td align="left" rowspan="1" colspan="1">2.77(1.85-4.24)</td>
<td align="left" rowspan="1" colspan="1">5.09(3.84-6.73)</td>
<td align="left" rowspan="1" colspan="1">2.77(2.11-3.62)</td>
<td align="left" rowspan="1" colspan="1">−0.05(−0.09--0.02)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330504.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t003fn001"><p><em>ASMR</em> Age-standardized mortality rate, <em>EAPC</em> Estimated annual percentage change, <em>CI</em> Confidence interval, <em>SDI</em> Socio-demographic index, <em>UI</em> Uncertainty interval.</p></div></div></section><section class="tw xbox font-sm" id="pone.0330504.t004"><h4 class="obj_head">Table 4. DALYs and ASDR of NAFLD in 1990 and 2021, and temporal trends.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">1990</th>
<th align="left" colspan="2" rowspan="1">2021</th>
<th align="left" rowspan="1" colspan="1">1990-2021 EAPC of ASDR (95%CI)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">DALYs, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASDR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1">DALYs, No. × 10<sup>3</sup>
</th>
<th align="left" rowspan="1" colspan="1">ASDR per 100,000 (95% UI)</th>
<th align="left" rowspan="1" colspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Global</strong>
</td>
<td align="left" rowspan="1" colspan="1">1689.25(1292.48-2206.53)</td>
<td align="left" rowspan="1" colspan="1">40.20(30.73-52.23)</td>
<td align="left" rowspan="1" colspan="1">3667.27(2903.58-4607.31)</td>
<td align="left" rowspan="1" colspan="1">42.40(33.60-53.31)</td>
<td align="left" rowspan="1" colspan="1">0.16(0.10-0.23)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Socio-Demographic Index</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">120.72(88.33-164.48)</td>
<td align="left" rowspan="1" colspan="1">47.45(34.47-64.59)</td>
<td align="left" rowspan="1" colspan="1">251.89(195.51-324.23)</td>
<td align="left" rowspan="1" colspan="1">42.89(33.61-55.57)</td>
<td align="left" rowspan="1" colspan="1">−0.42(−0.47--0.38)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Low-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">284.75(207.62-401.33)</td>
<td align="left" rowspan="1" colspan="1">41.94(30.32-58.47)</td>
<td align="left" rowspan="1" colspan="1">740.42(563.62-963.48)</td>
<td align="left" rowspan="1" colspan="1">47.65(35.77-61.75)</td>
<td align="left" rowspan="1" colspan="1">0.46(0.42-0.49)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">491.31(375.15-633.40)</td>
<td align="left" rowspan="1" colspan="1">42.14(32.23-54.23)</td>
<td align="left" rowspan="1" colspan="1">1260.02(991.41-1590.49)</td>
<td align="left" rowspan="1" colspan="1">45.53(36.02-56.74)</td>
<td align="left" rowspan="1" colspan="1">0.25(0.21-0.29)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-middle SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">386.00(294.44-496.60)</td>
<td align="left" rowspan="1" colspan="1">37.79(28.89-48.32)</td>
<td align="left" rowspan="1" colspan="1">713.36(554.27-916.76)</td>
<td align="left" rowspan="1" colspan="1">38.00(29.71-48.17)</td>
<td align="left" rowspan="1" colspan="1">0.02(−0.20-0.24)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High SDI</strong>
</td>
<td align="left" rowspan="1" colspan="1">404.32(313.34-522.66)</td>
<td align="left" rowspan="1" colspan="1">38.39(29.45-49.78)</td>
<td align="left" rowspan="1" colspan="1">697.59(548.69-876.32)</td>
<td align="left" rowspan="1" colspan="1">38.73(30.51-48.83)</td>
<td align="left" rowspan="1" colspan="1">0.02(−0.07-0.12)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Region</strong>
</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Andean Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">28.44(19.67-38.62)</td>
<td align="left" rowspan="1" colspan="1">124.44(86.26-170.30)</td>
<td align="left" rowspan="1" colspan="1">86.18(60.09-120.25)</td>
<td align="left" rowspan="1" colspan="1">142.16(98.60-198.78)</td>
<td align="left" rowspan="1" colspan="1">0.35(0.25-0.46)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Australasia</strong>
</td>
<td align="left" rowspan="1" colspan="1">4.96(3.78-6.48)</td>
<td align="left" rowspan="1" colspan="1">21.93(16.69-28.86)</td>
<td align="left" rowspan="1" colspan="1">15.51(12.41-18.96)</td>
<td align="left" rowspan="1" colspan="1">33.24(26.63-40.62)</td>
<td align="left" rowspan="1" colspan="1">1.63(1.49-1.77)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Caribbean</strong>
</td>
<td align="left" rowspan="1" colspan="1">20.07(14.40-26.82)</td>
<td align="left" rowspan="1" colspan="1">73.84(52.88-98.81)</td>
<td align="left" rowspan="1" colspan="1">42.92(30.01-59.39)</td>
<td align="left" rowspan="1" colspan="1">80.31(56.31-110.84)</td>
<td align="left" rowspan="1" colspan="1">0.25(−0.02-0.52)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">29.16(21.98-38.32)</td>
<td align="left" rowspan="1" colspan="1">57.94(43.86-76.18)</td>
<td align="left" rowspan="1" colspan="1">83.07(60.17-114.19)</td>
<td align="left" rowspan="1" colspan="1">92.24(67.18-124.97)</td>
<td align="left" rowspan="1" colspan="1">1.59(1.33-1.85)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">56.46(41.62-75.85)</td>
<td align="left" rowspan="1" colspan="1">38.08(28.09-51.07)</td>
<td align="left" rowspan="1" colspan="1">90.83(66.04-123.72)</td>
<td align="left" rowspan="1" colspan="1">47.90(34.85-64.84)</td>
<td align="left" rowspan="1" colspan="1">0.33(0.14-0.52)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">110.82(79.84-148.65)</td>
<td align="left" rowspan="1" colspan="1">115.68(82.48-156.37)</td>
<td align="left" rowspan="1" colspan="1">362.14(270.51-471.17)</td>
<td align="left" rowspan="1" colspan="1">138.84(104.37-180.55)</td>
<td align="left" rowspan="1" colspan="1">0.54(0.45-0.64)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Central Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">13.06(8.51-20.01)</td>
<td align="left" rowspan="1" colspan="1">47.73(31.27-74.29)</td>
<td align="left" rowspan="1" colspan="1">30.51(19.96-45.91)</td>
<td align="left" rowspan="1" colspan="1">43.12(28.16-65.78)</td>
<td align="left" rowspan="1" colspan="1">−0.44(−0.52--0.35)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>East Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">263.44(202.68-330.42)</td>
<td align="left" rowspan="1" colspan="1">27.43(21.28-34.39)</td>
<td align="left" rowspan="1" colspan="1">435.19(336.69-552.06)</td>
<td align="left" rowspan="1" colspan="1">20.11(15.61-25.11)</td>
<td align="left" rowspan="1" colspan="1">−0.92(−1.05--0.79)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">72.75(53.02-98.82)</td>
<td align="left" rowspan="1" colspan="1">26.28(19.11-35.14)</td>
<td align="left" rowspan="1" colspan="1">270.21(193.02-372.71)</td>
<td align="left" rowspan="1" colspan="1">91.40(65.18-125.26)</td>
<td align="left" rowspan="1" colspan="1">4.09(3.25-4.93)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Eastern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">47.08(35.63-61.64)</td>
<td align="left" rowspan="1" colspan="1">55.99(41.95-74.00)</td>
<td align="left" rowspan="1" colspan="1">113.48(85.89-151.39)</td>
<td align="left" rowspan="1" colspan="1">57.52(42.96-76.31)</td>
<td align="left" rowspan="1" colspan="1">−0.06(−0.12-0.00)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income Asia Pacific</strong>
</td>
<td align="left" rowspan="1" colspan="1">77.86(63.12-97.11)</td>
<td align="left" rowspan="1" colspan="1">37.92(30.69-47.13)</td>
<td align="left" rowspan="1" colspan="1">79.47(61.38-97.55)</td>
<td align="left" rowspan="1" colspan="1">18.75(14.82-23.05)</td>
<td align="left" rowspan="1" colspan="1">−2.54(−2.69--2.38)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>High-income North America</strong>
</td>
<td align="left" rowspan="1" colspan="1">98.11(74.31-129.09)</td>
<td align="left" rowspan="1" colspan="1">30.13(22.32-39.78)</td>
<td align="left" rowspan="1" colspan="1">241.65(188.29-307.00)</td>
<td align="left" rowspan="1" colspan="1">42.07(32.96-54.17)</td>
<td align="left" rowspan="1" colspan="1">1.36(1.20-1.51)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>North Africa and Middle East</strong>
</td>
<td align="left" rowspan="1" colspan="1">90.35(63.41-124.27)</td>
<td align="left" rowspan="1" colspan="1">53.96(37.45-78.19)</td>
<td align="left" rowspan="1" colspan="1">276.31(205.33-374.13)</td>
<td align="left" rowspan="1" colspan="1">58.96(43.63-79.78)</td>
<td align="left" rowspan="1" colspan="1">0.36(0.32-0.40)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Oceania</strong>
</td>
<td align="left" rowspan="1" colspan="1">0.94(0.60-1.49)</td>
<td align="left" rowspan="1" colspan="1">25.02(16.37-40.77)</td>
<td align="left" rowspan="1" colspan="1">2.06(1.46-2.89)</td>
<td align="left" rowspan="1" colspan="1">22.07(15.71-31.07)</td>
<td align="left" rowspan="1" colspan="1">−0.60(−0.72--0.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>South Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">209.50(151.60-294.20)</td>
<td align="left" rowspan="1" colspan="1">30.47(21.52-43.06)</td>
<td align="left" rowspan="1" colspan="1">540.64(397.35-722.27)</td>
<td align="left" rowspan="1" colspan="1">33.74(24.71-44.57)</td>
<td align="left" rowspan="1" colspan="1">0.28(0.25-0.31)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southeast Asia</strong>
</td>
<td align="left" rowspan="1" colspan="1">120.55(87.92-169.97)</td>
<td align="left" rowspan="1" colspan="1">41.58(30.11-59.29)</td>
<td align="left" rowspan="1" colspan="1">313.32(235.05-411.93)</td>
<td align="left" rowspan="1" colspan="1">45.34(34.02-58.79)</td>
<td align="left" rowspan="1" colspan="1">0.27(0.21-0.34)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">23.16(16.24-32.05)</td>
<td align="left" rowspan="1" colspan="1">49.62(34.83-68.63)</td>
<td align="left" rowspan="1" colspan="1">36.87(26.79-50.79)</td>
<td align="left" rowspan="1" colspan="1">43.99(31.93-60.55)</td>
<td align="left" rowspan="1" colspan="1">0.08(−0.06-0.22)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Southern Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">15.81(11.73-21.32)</td>
<td align="left" rowspan="1" colspan="1">49.55(36.00-69.25)</td>
<td align="left" rowspan="1" colspan="1">47.07(37.28-59.70)</td>
<td align="left" rowspan="1" colspan="1">72.65(57.59-91.06)</td>
<td align="left" rowspan="1" colspan="1">1.08(0.58-1.58)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Tropical Latin America</strong>
</td>
<td align="left" rowspan="1" colspan="1">37.57(27.87-50.07)</td>
<td align="left" rowspan="1" colspan="1">34.59(25.32-46.35)</td>
<td align="left" rowspan="1" colspan="1">101.28(74.62-133.35)</td>
<td align="left" rowspan="1" colspan="1">38.55(28.63-50.46)</td>
<td align="left" rowspan="1" colspan="1">0.53(0.42-0.64)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Europe</strong>
</td>
<td align="left" rowspan="1" colspan="1">304.93(225.76-399.48)</td>
<td align="left" rowspan="1" colspan="1">58.35(42.69-76.44)</td>
<td align="left" rowspan="1" colspan="1">349.70(269.84-441.85)</td>
<td align="left" rowspan="1" colspan="1">45.31(35.03-57.09)</td>
<td align="left" rowspan="1" colspan="1">−0.89(−1.07--0.70)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Western Sub-Saharan Africa</strong>
</td>
<td align="left" rowspan="1" colspan="1">64.23(44.11-93.54)</td>
<td align="left" rowspan="1" colspan="1">66.57(45.48-98.09)</td>
<td align="left" rowspan="1" colspan="1">148.87(110.16-198.13)</td>
<td align="left" rowspan="1" colspan="1">65.31(49.29-86.28)</td>
<td align="left" rowspan="1" colspan="1">−0.11(−0.15--0.07)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330504.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t004fn001"><p><em>ASDR</em> Age-standardized DALYs rate, <em>EAPC</em> Estimated annual percentage change, <em>CI</em> Confidence interval, <em>SDI</em> Socio-demographic index, <em>UI</em> Uncertainty interval.</p></div></div></section></section><section id="sec011"><h3 class="pmc_sec_title">NAFLD burden at national level</h3>
<p>At the national level in 2021, Egypt had the highest ASIR of NAFLD (1188.57 per 100 000 population), followed by Kuwait (1174.18 per 100 000 population), Iran (1168.68 per 100 000 population). Finland had the lowest ASIR of NAFLD (310.17 per 100 000 population), followed by Canada (311.21 per 100 000 population). Kuwait and Egypt also had the highest ASPR of NAFLD (32312.17 per 100 000 population, 31668.80 per 100 000 population). Japan and Finland had the lowest ASPR of NAFLD (8133.47 per 100 000 population, 8358.51 per 100 000 population) (<a href="#pone.0330504.g001" class="usa-link">Fig 1A</a>, <a href="#pone.0330504.g001" class="usa-link">1B</a>, <a href="#pone.0330504.s001" class="usa-link">S1 Table</a>). In 2021, Egypt and Mongolia had the highest ASMR of NAFLD (9.44 per 100 000 population, 8.64 per 100 000 population). Mexico and Egypt had the highest ASDR of NAFLD (201.86 per 100 000 population, 196.55 per 100 000 population) (<a href="#pone.0330504.g001" class="usa-link">Fig 1C</a>, <a href="#pone.0330504.g001" class="usa-link">1D</a>, <a href="#pone.0330504.s001" class="usa-link">S1 Table</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g001"><h4 class="obj_head">Fig 1. Global disease burden of NAFLD for both sexes in 204 countries and territories.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/f18d2ccf1b6d/pone.0330504.g001.jpg" loading="lazy" height="315" width="691" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The map images derive from open-source public domain data provided by Natural Earth. (A) ASIR of NAFLD in 2021; (B)ASPR of NAFLD in 2021; (C) ASMR of NAFLD in 2021; (D) ASDR of NAFLD in 2021.</p></figcaption></figure><p>At the national level from 1990 to 2019, both ASIR and ASPR showed an increase in all countries and territories. This means that the burden of NAFLD continues to increase. ASIR increased at the greatest rate in Equatorial Guinea (EAPC: 1.19), followed by Oman (EAPC: 0.99). ASPR increased at the greatest rate in Italy (EAPC: 1.21), followed by Oman (EAPC: 1.03) (<a href="#pone.0330504.g002" class="usa-link">Fig 2A</a>, <a href="#pone.0330504.g002" class="usa-link">2B</a>, <a href="#pone.0330504.s002" class="usa-link">S2 Table</a>). ASMR and ASDR had increased or decreased in various countries around the global. Russian Federation had the highest ASMR (EAPC: 4.25) and ASDR (EAPC: 4.82) increased rates (<a href="#pone.0330504.g002" class="usa-link">Fig 2C</a>, <a href="#pone.0330504.g002" class="usa-link">2D</a>, <a href="#pone.0330504.s002" class="usa-link">S2 Table</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g002"><h4 class="obj_head">Fig 2. Global temporal trend of NAFLD burden for both sexes in 204 countries and territories.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/4c6acb6ad125/pone.0330504.g002.jpg" loading="lazy" height="323" width="696" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The map images derive from open-source public domain data provided by Natural Earth. (A)EPAC of the ASIR in NAFLD; (B)EPAC of the ASPR in NAFLD; (C) EPAC of the ASMR in NAFLD; (D) EPAC of the ASDR in NAFLD.</p></figcaption></figure></section><section id="sec012"><h3 class="pmc_sec_title">NAFLD burden at regional level</h3>
<p>At the regional level, ASIR and ASPR presented inverted-U shape relationship with SDI (<a href="#pone.0330504.g004" class="usa-link">Fig 4A</a>, <a href="#pone.0330504.g004" class="usa-link">4B</a>). Middle SDI had the highest ASIR and ASPR from 1990 to 2021. High SDI had the lowest ASIR and ASPR from 1990 to 2021 (<a href="#pone.0330504.t001" class="usa-link">Tables 1</a> and <a href="#pone.0330504.t002" class="usa-link">2</a>, <a href="#pone.0330504.g003" class="usa-link">Fig 3</a>). In 2021, Low-middle SDI had the highest ASMR and ASDR, with High-middle SDI had the lowest ASMR and ASDR (<a href="#pone.0330504.t003" class="usa-link">Tables 3</a> and <a href="#pone.0330504.t004" class="usa-link">4</a>, <a href="#pone.0330504.g003" class="usa-link">Fig 3</a>). Low-middle SDI and Middle SDI showed an increase in ASMR and ASDR from 1990 to 2021 (<a href="#pone.0330504.g003" class="usa-link">Fig 3</a>, <a href="#pone.0330504.s003" class="usa-link">S3 Table</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g004"><h4 class="obj_head">Fig 4. Age-standardized rates of NAFLD among regions based on SDI from 1990 to 2021.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/20c6081d0482/pone.0330504.g004.jpg" loading="lazy" height="1738" width="791" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) ASIR; (B) ASPR; (C) ASMR; (D) ASDR.</p></figcaption></figure><figure class="fig xbox font-sm" id="pone.0330504.g003"><h4 class="obj_head">Fig 3. Trends in Global disease burden of NAFLD at Different SDI Levels from 1990 to 2021.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/8c77d39e5fde/pone.0330504.g003.jpg" loading="lazy" height="432" width="745" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>From 1990 to 2021, all 21 regions showed a sustained rise in ASIR and ASPR (<a href="#pone.0330504.g004" class="usa-link">Fig 4A</a>, <a href="#pone.0330504.g004" class="usa-link">4B</a>). North Africa and Middle East had the highest ASIR (1037.64 per 100 000 population) and ASPR (27686.69 per 100 000 population) in 2021 (<a href="#pone.0330504.t001" class="usa-link">Tables 1</a> and <a href="#pone.0330504.t002" class="usa-link">2</a>), higher than that of the expected level based on SDI from 1990 to 2021 (<a href="#pone.0330504.g004" class="usa-link">Fig 4A</a>, <a href="#pone.0330504.g004" class="usa-link">4B</a>, <a href="#pone.0330504.s004" class="usa-link">S4 Table</a>). ASIR increased at the greatest rate in East Asia (EAPC: 0.73) and Western Europe (EAPC: 0.73). ASPR increased at the greatest rate in Western Europe (EAPC: 0.98), followed by High-income North America (EAPC: 0.89) (<a href="#pone.0330504.t001" class="usa-link">Tables 1</a> and <a href="#pone.0330504.t002" class="usa-link">2</a>).</p>
<p>In 2021, Andean Latin America and Central Latin America had the highest ASMR (5.89 per 100 000 population, 5.00 per 100 000 population) and ASDR (142.16 per 100 000 population, 138.84 per 100 000 population) (<a href="#pone.0330504.t003" class="usa-link">Tables 3</a>,<a href="#pone.0330504.t004" class="usa-link">4</a>), higher than that of the expected level based on SDI from 1990 to 2021 (<a href="#pone.0330504.g004" class="usa-link">Fig 4C</a>, <a href="#pone.0330504.g004" class="usa-link">4D</a>, <a href="#pone.0330504.s004" class="usa-link">S4 Table</a>). Eastern Europe had the highest ASMR (EAPC: 3.58) and ASDR (EAPC: 4.09) increased rates (<a href="#pone.0330504.t003" class="usa-link">Tables 3</a>,<a href="#pone.0330504.t004" class="usa-link">4</a>).</p></section><section id="sec013"><h3 class="pmc_sec_title">Age and sex patterns</h3>
<p>In 2021, the highest number of incidence cases and incidence rates were in 20–24 years group, and these gradually declined with age (<a href="#pone.0330504.g005" class="usa-link">Fig 5A</a>, <a href="#pone.0330504.s005" class="usa-link">S5 Table</a>). The incidence of NAFLD in young people was higher than that in middle-aged and older people, reflecting a tendency towards a younger onset of NAFLD. The number of incidence cases and incidence rates were apparently higher in males than in females before the age of 45, which may mean that younger men are more likely to develop NAFLD (<a href="#pone.0330504.g005" class="usa-link">Fig 5A</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g005"><h4 class="obj_head">Fig 5. Global disease burden of NAFLD in males and females by different age group in 2021.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/20194577f876/pone.0330504.g005.jpg" loading="lazy" height="501" width="750" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) incidence cases and ASIR; (B) prevalence cases and ASPR; (C) death cases and ASMR; (D) DALYs and ASDR.</p></figcaption></figure><p>In 2021, the number of prevalence cases presented inverted-U shape relationship with age, the highest number of prevalence cases was in 45–49 years group. The prevalence rates of NAFLD gradually increased with age until it peaked in 75–79 years group (<a href="#pone.0330504.g005" class="usa-link">Fig 5B</a>).</p>
<p>ASMR and ASDR were observed to exhibit a progressive increase with advancing age. The number of death cases and DALYs presented inverted-U shape relationship with age. The highest number of death cases was in 65–69 years group, with the highest number of DALYs was in 55–59 years group (<a href="#pone.0330504.g005" class="usa-link">Fig 5C</a>, <a href="#pone.0330504.g005" class="usa-link">5D</a>).</p></section><section id="sec014"><h3 class="pmc_sec_title">Risk factors attributable to NAFLD burden</h3>
<p>To further identify risk factors for NAFLD, we conducted a detailed analysis of global data from 1990 to 2021. High fasting plasma glucose and Tobacco were the main risk factors for NAFLD (<a href="#pone.0330504.g006" class="usa-link">Fig 6</a>, <a href="#pone.0330504.s006" class="usa-link">S6 Table</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g006"><h4 class="obj_head">Fig 6. Main risk factors for NAFLD from 1990 to 2021.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/ecc9042fded5/pone.0330504.g006.jpg" loading="lazy" height="280" width="699" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) the proportion of deaths attributed to risk factors. (B) the proportion of DALYs attributed to risk factors.</p></figcaption></figure><p>Globally, the proportion of deaths attributed to high fasting plasma glucose was 4.07% in1990, and increased to 7.32% in 2021. Consistent with the proportion of deaths, the proportion of DALYs attributed to high fasting plasma glucose was 3.41% in 1990, and increased to 5.85% in 2021. Significant increases were observed to varying degrees in high SDI, high-middle SDI, middle SDI, low-middle SDI, and low SDI regions. These suggested the importance of fasting plasma glucose management for NAFLD control (<a href="#pone.0330504.g006" class="usa-link">Fig 6A</a>, <a href="#pone.0330504.g006" class="usa-link">6B</a>).</p>
<p>As for the other main risk factor, the proportion of deaths attributed to tobacco was 2.44% in 1990, and 2.49% in 2021. Similar with the proportion of deaths, the proportion of DALYs attributed to tobacco was 2.51% in 1990, and 2.38% in 2021. There were no clear change trends overall (<a href="#pone.0330504.g006" class="usa-link">Fig 6A</a>, <a href="#pone.0330504.g006" class="usa-link">6B</a>).</p></section><section id="sec015"><h3 class="pmc_sec_title">Projection of NAFLD</h3>
<p>To learn about the trends of NAFLD after 2021, we used Bayesian age-period-cohort models to predict the ASIR, ASPR, ASMR from 2021 to 2035 (<a href="#pone.0330504.g007" class="usa-link">Fig 7</a>, <a href="#pone.0330504.s007" class="usa-link">S7 Table</a>). The projections suggest that the ASIR will continue to rise consistently after 2021, from 595.12 per 100000 in 2021 to 649.41 per 100000 in 2035 (<a href="#pone.0330504.g007" class="usa-link">Fig 7A</a>). Consistent with the ASIR, the ASPR will also continue to rise, from 15053.24 per 100,000 in 2021 to 16059.91 per 100,000 in 2035 (<a href="#pone.0330504.g007" class="usa-link">Fig 7B</a>). The overall burden of disease will continue to increase over time. ASMR may also increase with time, from 1.63 per 100000 in 2021 to 1.67 per 100000 in 2035 (<a href="#pone.0330504.g007" class="usa-link">Fig 7C</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330504.g007"><h4 class="obj_head">Fig 7. Trends in the NAFLD-related ASIR, ASPR, ASMR in the Global (BAPC models): observed (dashed lines) and predicted rates (solid lines).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373163_pone.0330504.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d473/12373163/52331603dd8b/pone.0330504.g007.jpg" loading="lazy" height="706" width="660" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330504.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Trends in ASIR; (B) Trends in ASPR; (C) Trends in ASMR.</p></figcaption></figure></section></section><section id="sec016"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this study, we leveraged publicly available modeling data and methodologies from the GBD 2021 to present the most up-to-date and comprehensive information on the incidence, prevalence, mortality, and Disability-Adjusted Life Years (DALYs) rates of NAFLD across 204 countries and territories from 1990 to 2021. Our findings contribute to estimating the global health impact of NAFLD.</p>
<p>Our data reveals a substantial surge in the global prevalence of NAFLD from 1990 to 2021, with an estimated 48.35 million cases in 2021, marking a 94% increase from the 24.86 million cases recorded in 1990. The Age-Standardized Incidence Rate (ASIR) of NAFLD rose by 25%, while the Age-Standardized Prevalence Rate (ASPR) increased by 24%. Furthermore, there was an upward trend in both NAFLD-related deaths and Disability-Adjusted Life Years (DALYs) between 1990 and 2021. These results underscore the continuing significant health, economic, and societal ramifications of NAFLD. With the escalating prevalence and related diseases, the healthcare, nursing expenses, and financial strain posed by NAFLD are exceptionally heavy [<a href="#pone.0330504.ref024" class="usa-link" aria-describedby="pone.0330504.ref024">24</a>]. In the United States, the estimated lifelong nursing costs for all NASH patients in 2017 amounted to approximately $222 billion [<a href="#pone.0330504.ref025" class="usa-link" aria-describedby="pone.0330504.ref025">25</a>]. Younossi et al. found that for obese patients with NASH, the cumulative direct medical costs were expected to be $1208.47 billion, while for patients with NASH but not obese, the cumulative direct medical costs were expected to be $453.88 billion [<a href="#pone.0330504.ref026" class="usa-link" aria-describedby="pone.0330504.ref026">26</a>]. By 2039, the medical costs caused by NASH per patient are expected to increase from $3636 to $6968. In Europe, the total costs related to NASH in 2018 ranged from 8.548 billion euros to 19.546 billion euros.</p>
<p>In this analysis, we found significant differences in the regional NAFLD prevalence rates. In 2021, the regions of North Africa and the Middle East exhibited ASIR of 1037.64 per 100,000 population and ASPR of 27686.69 per 100,000 population. Meanwhile, the Andean and Central Latin American regions reported ASMR of 5.89 and 5.00 per 100,000 population, respectively, and ASDR of 142.16 and 138.84 per 100,000 population, respectively, for the same year. The data presented in this article holds significant importance. Although NAFLD was initially considered a “Western” disease, it affects one-third of the population worldwide. In fact, NAFLD is more prevalent in regions that are still developing, such as South America, the Middle East and North Africa, Asia, and many other countries [<a href="#pone.0330504.ref003" class="usa-link" aria-describedby="pone.0330504.ref003">3</a>]. Middle SDI regions experience rapid urbanization-driven dietary shifts and sedentary lifestyles, outpacing preventive healthcare capacity, creating unchecked obesogenic environments. High SDI regions benefit from established public health interventions and health literacy. Nationwide NAFLD screening in countries enables early intervention. This critical regional outliers beyond socioeconomic gradients not merely from SDI gradients but distinct pathogenic landscapes. In North Africa/Middle East, genetic susceptibility interacts with rapid nutrition transitions—characterized by surging consumption of sugar-sweetened beverages and palm oil—and endemic hypovitaminosis D (&gt;80% prevalence) [<a href="#pone.0330504.ref027" class="usa-link" aria-describedby="pone.0330504.ref027">27</a>], collectively amplifying steatosis risk independently of obesity [<a href="#pone.0330504.ref028" class="usa-link" aria-describedby="pone.0330504.ref028">28</a>,<a href="#pone.0330504.ref029" class="usa-link" aria-describedby="pone.0330504.ref029">29</a>]. The overall trend is that the rate of increase in obesity is highest in low- to lower-middle-income countries, potentially due to significant socioeconomic disparities leading to differences in diet and exercise levels. It is apparent that individuals with a lower socioeconomic status (SES) exhibit higher mortality rates in cases of NAFLD, and socially marginalized groups are at an elevated risk of contracting NAFLD and its associated complications [<a href="#pone.0330504.ref030" class="usa-link" aria-describedby="pone.0330504.ref030">30</a>]. Conversely, Latin America’s mortality crisis reflects structural healthcare constraints. Delayed diagnosis occurs due to critical shortages in non – invasive diagnostics. Also, there is limited tertiary care for advanced cirrhosis and negligible transplant access. At the same time, syndemic comorbidities compound the problem [<a href="#pone.0330504.ref031" class="usa-link" aria-describedby="pone.0330504.ref031">31</a>]. In light of this correlation between SES and health, future global initiatives ought to focus on advancing these elements across the population [<a href="#pone.0330504.ref032" class="usa-link" aria-describedby="pone.0330504.ref032">32</a>]. This encompasses guaranteeing universal access to nutritious diets, education, pedestrian-friendly environments, and top-notch healthcare services as strategic measures to alleviate the NAFLD burden.</p>
<p>Our results indicate that in 2021, the highest number of cases and incidence rate of NAFLD were observed in the 20–24 age group, with a gradual decline as age increases. The onset age of nonalcoholic fatty liver disease (NAFLD) is decreasing. Alarmingly, an increasing number of individuals are developing NAFLD at younger ages, which means they have more time to develop severe complications, leading to an increased burden on families and society in terms of medical care. In addition, our study findings reveal that young males are more prone to developing NAFLD than their female counterparts. Similarly, research has indicated that prior to menopause, females exhibit a reduced risk of NAFLD compared to males, but this disparity diminishes post-menopause, with similar NAFLD prevalence observed between the sexes [<a href="#pone.0330504.ref033" class="usa-link" aria-describedby="pone.0330504.ref033">33</a>]. Della Torre S. highlights that women with reproductive disorders marked by altered estrogen levels, notably polycystic ovary syndrome (PCOS), have a heightened incidence of NAFLD relative to women of typical reproductive age [<a href="#pone.0330504.ref034" class="usa-link" aria-describedby="pone.0330504.ref034">34</a>]. These results further underscore the protective effects of estrogen. Liver ERα signaling enables females, but not males, to mount a metabolic response to excessive dietary lipids, thereby limiting hepatic lipid accumulation in a mouse model of diet-induced NAFLD [<a href="#pone.0330504.ref035" class="usa-link" aria-describedby="pone.0330504.ref035">35</a>]. Liver ERα may serve as a sensor of hormonal and nutritional status, exerting distinct effects on hepatic metabolic regulation in both sexes, thus contributing to the gender disparity in NAFLD susceptibility [<a href="#pone.0330504.ref036" class="usa-link" aria-describedby="pone.0330504.ref036">36</a>,<a href="#pone.0330504.ref037" class="usa-link" aria-describedby="pone.0330504.ref037">37</a>].</p>
<p>Our study pinpoints fasting blood glucose levels and tobacco use as key risk factors for NAFLD. A study indicates that there is an independent non-linear association between fasting blood glucose and NAFLD among non-obese Chinese individuals with normal lipid levels, and an elevation in fasting blood glucose may suggest an increased risk of NAFLD [<a href="#pone.0330504.ref038" class="usa-link" aria-describedby="pone.0330504.ref038">38</a>]. Elevated fasting blood glucose levels may increase the risk of NAFLD through multiple mechanisms. Numerous studies have shown that glucose stimulates de novo lipogenesis (DNL) in the liver by activating the carbohydrate-responsive element-binding protein (ChREBP) [<a href="#pone.0330504.ref039" class="usa-link" aria-describedby="pone.0330504.ref039">39</a>]. Furthermore, research indicates that fluctuations in glucose levels increase oxidative stress both in vivo and in vitro, leading to hepatocyte apoptosis, fibrosis, and inflammation [<a href="#pone.0330504.ref040" class="usa-link" aria-describedby="pone.0330504.ref040">40</a>]. This suggests that further exploration of the role of fasting blood glucose levels in NAFLD outcomes is of potential importance. Increasing amounts of data suggest that both passive and active smoking may be environmental stressors contributing to the progression of NAFLD [<a href="#pone.0330504.ref041" class="usa-link" aria-describedby="pone.0330504.ref041">41</a>–<a href="#pone.0330504.ref043" class="usa-link" aria-describedby="pone.0330504.ref043">43</a>], indicating that smoking may alter the regulatory role of AMP-activated kinase in lipid metabolism. Future studies should closely investigate the clinical relevance of smoking and NAFLD. However, in the meantime, smoking cessation can be considered in the management of NAFLD patients.</p>
<p>To gain deeper insights into the global trends of NAFLD post-2021, we employed a Bayesian Age-Period-Cohort model to precisely predict and analyze the ASIR, ASPR, and ASMR within this population cohort from 2021 to 2035. Over time, the global trend of NAFLD is projected to exhibit a sustained increase in prevalence and an escalating disease burden. Consequently, addressing this growing burden necessitates tailored interventions (such as adopting a Mediterranean diet, weight loss, exercise, and raising awareness) for different regions [<a href="#pone.0330504.ref044" class="usa-link" aria-describedby="pone.0330504.ref044">44</a>]. Furthermore, NAFLD as a global health issue underscores the need for attention from the World Health Organization (WHO) to tackle this escalating health concern worldwide.</p>
<p>Our study also has limitations. The first significant limitation is the underrepresentation of less developed countries in the reported epidemiological data on NAFLD. Secondly, as the research is based on the GBD 2021 database, currently only risk factor estimates at the national and regional levels are provided, and it is still impossible to conduct analyses at a finer granularity (such as provincial or city-level). Therefore, we are unable to assess the differences in risk factor exposure among different regions within a country, which to some extent limits the application of the results in local public health decision-making. Thirdly, individual SDI components—including adolescent fertility rates, population education levels, and per capita income—and NAFLD burden. Future research should disentangle how specific SDI components—particularly education gaps, income inequality, and early fertility patterns—independently modulate NAFLD epidemiology through individual-level studies, complementing our macro-level assessment. Another important limitation is the unexplained heterogeneity observed in some of the studies included in our analysis.</p>
<p>In summary, our study is an up-to-date assessment of the worldwide NAFLD, encompassing 204 nations, 21 regions with disease burdens, and 5 SDI areas, which had not been assessed before. Our findings reveal a 24% increase in the prevalence of NAFLD over the span of three decades. Notably, in 2021, countries with a medium SDI exhibited the highest ASIR and ASPR. Additionally, the Middle East and North Africa reported the highest NAFLD prevalence. That same year, the 20–24 age bracket accounted for the highest number of cases and incidence rates, with a subsequent decline as age advanced, indicating a shifting trend towards younger onset of NAFLD. Notably, metabolic risk factors in children and adolescents constitute one of the biggest threats to global health in the coming decades. We anticipate a steady escalation in the global NAFLD burden by 2035, imposing substantial societal strain. As NAFLD is reversible, initiating public health initiatives to enhance awareness, improve diagnostic accuracy, and encourage dietary and exercise interventions can mitigate the projected surge in disease burden.</p></section><section id="sec017"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330504.s001"><div class="caption p">
<span>S1 Table. ASIR, ASPR, ASMR, ASDR of NAFLD for both sexes in 204 countries and territories in 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s001.xlsx</a><sup> (67.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s002"><div class="caption p">
<span>S2 Table. EAPC of the ASIR, ASPR, ASMR, ASDR for both sexes in NAFLD in 204 countries and territories from 1990–2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s002.xlsx</a><sup> (34.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s003"><div class="caption p">
<span>S3 Table. ASIR, ASPR, ASMR, ASDR trends in global disease burden of NAFLD at different SDI levels from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s003.xlsx</a><sup> (54.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s004"><div class="caption p">
<span>S4 Table. ASIR, ASPR, ASMR, ASDR of NAFLD among regions based on SDI from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s004.xlsx</a><sup> (181.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s005"><div class="caption p">
<span>S5 Table. Global disease burden of NAFLD in males and females by different age group in 2021.</span><p>Incidence cases and ASIR; prevalence cases and ASPR; death cases and ASMR; DALYs and ASDR.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s005.xlsx</a><sup> (34.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s006"><div class="caption p">
<span>S6 Table. The proportion of deaths and DALYs attributed to risk factors of NAFLD from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s006.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s006.xlsx</a><sup> (37.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330504.s007"><div class="caption p">
<span>S7 Table. Trends in the NAFLD-related ASIR, ASPR, ASMR in the global (BAPC models).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s007.xlsx</a><sup> (20.6KB, xlsx) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations:</h2>
<dl class="def-list">
<dt>NAFLD</dt>
<dd><p>non-alcoholic fatty liver disease</p></dd>
<dt>GBD</dt>
<dd><p>Global Burden of Disease</p></dd>
<dt>ASR</dt>
<dd><p>Age-standardized rate</p></dd>
<dt>ASIR</dt>
<dd><p>Age-standardized incidence rate</p></dd>
<dt>ASPR</dt>
<dd><p>Age-standardized prevalence rate</p></dd>
<dt>ASMR</dt>
<dd><p>: age-standardized mortality rate</p></dd>
<dt>ASDR</dt>
<dd><p>Age-standardized DALYs rate</p></dd>
<dt>DALYs</dt>
<dd><p>Disability-adjusted life years</p></dd>
<dt>EAPC</dt>
<dd><p>Estimated annual percentage change</p></dd>
<dt>SDI</dt>
<dd><p>Socio-demographic index</p></dd>
<dt>UI</dt>
<dd><p>Uncertainty interval</p></dd>
<dt>CI</dt>
<dd><p>confidence interval</p></dd>
<dt>BAPC</dt>
<dd><p>Bayesian age-period-cohort</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>The datasets for this article are available from the Global Health Data Exchange query tool (<a href="http://ghdx.healthdata.org/gbd-results-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://ghdx.healthdata.org/gbd-results-tool</a>).</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This study was supported by the Shanghai Medical Innovation and Development Foundation, the Yangtze River Delta pharmaceutical high-quality development research promotion program (SMIDF-142-3 to M.W.).</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330504.ref001">
<span class="label">1.</span><cite>Gofton C, Upendran Y, Zheng M-H, George J. MAFLD: How is it different from NAFLD?
Clin Mol Hepatol. 2023;29(Suppl):S17–31. doi: 10.3350/cmh.2022.0367

</cite> [<a href="https://doi.org/10.3350/cmh.2022.0367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10029949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36443926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Mol%20Hepatol&amp;title=MAFLD:%20How%20is%20it%20different%20from%20NAFLD?&amp;author=C%20Gofton&amp;author=Y%20Upendran&amp;author=M-H%20Zheng&amp;author=J%20George&amp;volume=29&amp;publication_year=2023&amp;pmid=36443926&amp;doi=10.3350/cmh.2022.0367&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref002">
<span class="label">2.</span><cite>Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109

</cite> [<a href="https://doi.org/10.1038/nrgastro.2017.109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28930295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Gastroenterol%20Hepatol&amp;title=Global%20burden%20of%20NAFLD%20and%20NASH:%20trends,%20predictions,%20risk%20factors%20and%20prevention&amp;author=Z%20Younossi&amp;author=QM%20Anstee&amp;author=M%20Marietti&amp;author=T%20Hardy&amp;author=L%20Henry&amp;volume=15&amp;issue=1&amp;publication_year=2018&amp;pages=11-20&amp;pmid=28930295&amp;doi=10.1038/nrgastro.2017.109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref003">
<span class="label">3.</span><cite>Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–47. doi: 10.1097/HEP.0000000000000004

</cite> [<a href="https://doi.org/10.1097/HEP.0000000000000004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10026948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36626630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The%20global%20epidemiology%20of%20nonalcoholic%20fatty%20liver%20disease%20(NAFLD)%20and%20nonalcoholic%20steatohepatitis%20(NASH):%20a%20systematic%20review&amp;author=ZM%20Younossi&amp;author=P%20Golabi&amp;author=JM%20Paik&amp;author=A%20Henry&amp;author=C%20Van%20Dongen&amp;volume=77&amp;issue=4&amp;publication_year=2023&amp;pages=1335-47&amp;pmid=36626630&amp;doi=10.1097/HEP.0000000000000004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref004">
<span class="label">4.</span><cite>Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: Definition and subtypes. Clin Mol Hepatol. 2023;29(suppl):S5–16. doi: 10.3350/cmh.2022.0424

</cite> [<a href="https://doi.org/10.3350/cmh.2022.0424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10029964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36577427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Mol%20Hepatol&amp;title=Non-alcoholic%20fatty%20liver%20disease:%20Definition%20and%20subtypes&amp;author=SK%20Han&amp;author=SK%20Baik&amp;author=MY%20Kim&amp;volume=29&amp;publication_year=2023&amp;pmid=36577427&amp;doi=10.3350/cmh.2022.0424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref005">
<span class="label">5.</span><cite>Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56(11):951–63. doi: 10.1007/s00535-021-01796-x

</cite> [<a href="https://doi.org/10.1007/s00535-021-01796-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8531062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34533632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gastroenterol&amp;title=Evidence-based%20clinical%20practice%20guidelines%20for%20nonalcoholic%20fatty%20liver%20disease/nonalcoholic%20steatohepatitis%202020&amp;author=K%20Tokushige&amp;author=K%20Ikejima&amp;author=M%20Ono&amp;author=Y%20Eguchi&amp;author=Y%20Kamada&amp;volume=56&amp;issue=11&amp;publication_year=2021&amp;pages=951-63&amp;pmid=34533632&amp;doi=10.1007/s00535-021-01796-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref006">
<span class="label">6.</span><cite>Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–55. doi: 10.1053/j.gastro.2014.11.039

</cite> [<a href="https://doi.org/10.1053/j.gastro.2014.11.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25461851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Nonalcoholic%20steatohepatitis%20is%20the%20second%20leading%20etiology%20of%20liver%20disease%20among%20adults%20awaiting%20liver%20transplantation%20in%20the%20United%20States&amp;author=RJ%20Wong&amp;author=M%20Aguilar&amp;author=R%20Cheung&amp;author=RB%20Perumpail&amp;author=SA%20Harrison&amp;volume=148&amp;issue=3&amp;publication_year=2015&amp;pages=547-55&amp;pmid=25461851&amp;doi=10.1053/j.gastro.2014.11.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref007">
<span class="label">7.</span><cite>Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–53. doi: 10.1136/gutjnl-2017-313884

</cite> [<a href="https://doi.org/10.1136/gutjnl-2017-313884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28314735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Non-alcoholic%20fatty%20liver%20disease%20and%20its%20relationship%20with%20cardiovascular%20disease%20and%20other%20extrahepatic%20diseases&amp;author=LA%20Adams&amp;author=QM%20Anstee&amp;author=H%20Tilg&amp;author=G%20Targher&amp;volume=66&amp;issue=6&amp;publication_year=2017&amp;pages=1138-53&amp;pmid=28314735&amp;doi=10.1136/gutjnl-2017-313884&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref008">
<span class="label">8.</span><cite>Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Sci Rep. 2016;6:33386. doi: 10.1038/srep33386

</cite> [<a href="https://doi.org/10.1038/srep33386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5026028/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27633274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Association%20of%20non-alcoholic%20fatty%20liver%20disease%20with%20major%20adverse%20cardiovascular%20events:%20A%20systematic%20review%20and%20meta-analysis&amp;author=S%20Wu&amp;author=F%20Wu&amp;author=Y%20Ding&amp;author=J%20Hou&amp;author=J%20Bi&amp;volume=6&amp;publication_year=2016&amp;pages=33386&amp;pmid=27633274&amp;doi=10.1038/srep33386&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref009">
<span class="label">9.</span><cite>Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012;10(6):646–50. doi: 10.1016/j.cgh.2011.12.039

</cite> [<a href="https://doi.org/10.1016/j.cgh.2011.12.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22245962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Gastroenterol%20Hepatol&amp;title=Independent%20association%20between%20nonalcoholic%20fatty%20liver%20disease%20and%20cardiovascular%20disease%20in%20the%20US%20population&amp;author=M%20Stepanova&amp;author=ZM%20Younossi&amp;volume=10&amp;issue=6&amp;publication_year=2012&amp;pages=646-50&amp;pmid=22245962&amp;doi=10.1016/j.cgh.2011.12.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref010">
<span class="label">10。.</span><cite>Käräjämäki AJ, Pätsi O-P, Savolainen M, Kesäniemi YA, Huikuri H, Ukkola O. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLoS One. 2015;10(11):e0142937. doi: 10.1371/journal.pone.0142937

</cite> [<a href="https://doi.org/10.1371/journal.pone.0142937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4646339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26571029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Non-Alcoholic%20Fatty%20Liver%20Disease%20as%20a%20Predictor%20of%20Atrial%20Fibrillation%20in%20Middle-Aged%20Population%20(OPERA%20Study)&amp;author=AJ%20K%C3%A4r%C3%A4j%C3%A4m%C3%A4ki&amp;author=O-P%20P%C3%A4tsi&amp;author=M%20Savolainen&amp;author=YA%20Kes%C3%A4niemi&amp;author=H%20Huikuri&amp;volume=10&amp;issue=11&amp;publication_year=2015&amp;pmid=26571029&amp;doi=10.1371/journal.pone.0142937&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref011">
<span class="label">11.</span><cite>Targher G, Mantovani A, Pichiri I, Mingolla L, Cavalieri V, Mantovani W, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care. 2014;37(6):1729–36. doi: 10.2337/dc13-2704

</cite> [<a href="https://doi.org/10.2337/dc13-2704" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24696459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Nonalcoholic%20fatty%20liver%20disease%20is%20independently%20associated%20with%20an%20increased%20incidence%20of%20chronic%20kidney%20disease%20in%20patients%20with%20type%201%20diabetes&amp;author=G%20Targher&amp;author=A%20Mantovani&amp;author=I%20Pichiri&amp;author=L%20Mingolla&amp;author=V%20Cavalieri&amp;volume=37&amp;issue=6&amp;publication_year=2014&amp;pages=1729-36&amp;pmid=24696459&amp;doi=10.2337/dc13-2704&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref012">
<span class="label">12.</span><cite>Ming J, Xu S, Gao B, Liu G, Ji Y, Yang F, et al. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi’an, China: a five-year cohort study. Liver Int. 2015;35(11):2401–7. doi: 10.1111/liv.12851

</cite> [<a href="https://doi.org/10.1111/liv.12851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25879672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Non-alcoholic%20fatty%20liver%20disease%20predicts%20type%202%20diabetes%20mellitus,%20but%20not%20prediabetes,%20in%20Xi%E2%80%99an,%20China:%20a%20five-year%20cohort%20study&amp;author=J%20Ming&amp;author=S%20Xu&amp;author=B%20Gao&amp;author=G%20Liu&amp;author=Y%20Ji&amp;volume=35&amp;issue=11&amp;publication_year=2015&amp;pages=2401-7&amp;pmid=25879672&amp;doi=10.1111/liv.12851&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref013">
<span class="label">13.</span><cite>Sung K-C, Kim SH. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab. 2011;96(4):1093–7. doi: 10.1210/jc.2010-2190

</cite> [<a href="https://doi.org/10.1210/jc.2010-2190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3070249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21252243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Interrelationship%20between%20fatty%20liver%20and%20insulin%20resistance%20in%20the%20development%20of%20type%202%20diabetes&amp;author=K-C%20Sung&amp;author=SH%20Kim&amp;volume=96&amp;issue=4&amp;publication_year=2011&amp;pages=1093-7&amp;pmid=21252243&amp;doi=10.1210/jc.2010-2190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref014">
<span class="label">14.</span><cite>Estes C, Chan HLY, Chien RN, Chuang W-L, Fung J, Goh GB-B, et al. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020;51(8):801–11. doi: 10.1111/apt.15673

</cite> [<a href="https://doi.org/10.1111/apt.15673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7154715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32133676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aliment%20Pharmacol%20Ther&amp;title=Modelling%20NAFLD%20disease%20burden%20in%20four%20Asian%20regions-2019-2030&amp;author=C%20Estes&amp;author=HLY%20Chan&amp;author=RN%20Chien&amp;author=W-L%20Chuang&amp;author=J%20Fung&amp;volume=51&amp;issue=8&amp;publication_year=2020&amp;pages=801-11&amp;pmid=32133676&amp;doi=10.1111/apt.15673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref015">
<span class="label">15.</span><cite>Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi: 10.1002/hep.28431

</cite> [<a href="https://doi.org/10.1002/hep.28431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26707365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Global%20epidemiology%20of%20nonalcoholic%20fatty%20liver%20disease-Meta-analytic%20assessment%20of%20prevalence,%20incidence,%20and%20outcomes&amp;author=ZM%20Younossi&amp;author=AB%20Koenig&amp;author=D%20Abdelatif&amp;author=Y%20Fazel&amp;author=L%20Henry&amp;volume=64&amp;issue=1&amp;publication_year=2016&amp;pages=73-84&amp;pmid=26707365&amp;doi=10.1002/hep.28431&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref016">
<span class="label">16.</span><cite>Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–98. doi: 10.1016/S2468-1253(19)30039-1

</cite> [<a href="https://doi.org/10.1016/S2468-1253(19)30039-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30902670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Gastroenterol%20Hepatol&amp;title=Prevalence,%20incidence,%20and%20outcome%20of%20non-alcoholic%20fatty%20liver%20disease%20in%20Asia,%201999-2019:%20a%20systematic%20review%20and%20meta-analysis&amp;author=J%20Li&amp;author=B%20Zou&amp;author=YH%20Yeo&amp;author=Y%20Feng&amp;author=X%20Xie&amp;volume=4&amp;issue=5&amp;publication_year=2019&amp;pages=389-98&amp;pmid=30902670&amp;doi=10.1016/S2468-1253(19)30039-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref017">
<span class="label">17.</span><cite>Nakatsuka T, Tateishi R, Koike K. Changing clinical management of NAFLD in Asia. Liver Int. 2022;42(9):1955–68. doi: 10.1111/liv.15046

</cite> [<a href="https://doi.org/10.1111/liv.15046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34459096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Int&amp;title=Changing%20clinical%20management%20of%20NAFLD%20in%20Asia&amp;author=T%20Nakatsuka&amp;author=R%20Tateishi&amp;author=K%20Koike&amp;volume=42&amp;issue=9&amp;publication_year=2022&amp;pages=1955-68&amp;pmid=34459096&amp;doi=10.1111/liv.15046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref018">
<span class="label">18.</span><cite>Wei S, Wang L, Evans PC, Xu S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 2024;29(3):103910. doi: 10.1016/j.drudis.2024.103910

</cite> [<a href="https://doi.org/10.1016/j.drudis.2024.103910" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38301798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discov%20Today&amp;title=NAFLD%20and%20NASH:%20etiology,%20targets%20and%20emerging%20therapies&amp;author=S%20Wei&amp;author=L%20Wang&amp;author=PC%20Evans&amp;author=S%20Xu&amp;volume=29&amp;issue=3&amp;publication_year=2024&amp;pages=103910&amp;pmid=38301798&amp;doi=10.1016/j.drudis.2024.103910&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref019">
<span class="label">19.</span><cite>Nassir F. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules. 2022;12(6):824. doi: 10.3390/biom12060824

</cite> [<a href="https://doi.org/10.3390/biom12060824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9221336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35740949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=NAFLD:%20Mechanisms,%20Treatments,%20and%20Biomarkers&amp;author=F%20Nassir&amp;volume=12&amp;issue=6&amp;publication_year=2022&amp;pages=824&amp;pmid=35740949&amp;doi=10.3390/biom12060824&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref020">
<span class="label">20.</span><cite>GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. doi: 10.1016/S0140-6736(20)30925-9

</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)30925-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7567026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33069326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Global%20burden%20of%20369%20diseases%20and%20injuries%20in%20204%20countries%20and%20territories,%201990-2019:%20a%20systematic%20analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202019&amp;author=Collaborators%20GBD%202019%20Diseases%20and%20Injuries&amp;volume=396&amp;issue=10258&amp;publication_year=2020&amp;pages=1204-22&amp;pmid=33069326&amp;doi=10.1016/S0140-6736(20)30925-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref021">
<span class="label">21.</span><cite>Qian X, Wan J, Xu J, Liu C, Zhong M, Zhang J, et al. Epidemiological Trends of Urolithiasis at the Global, Regional, and National Levels: A Population-Based Study. Int J Clin Pract. 2022;2022:6807203. doi: 10.1155/2022/6807203

</cite> [<a href="https://doi.org/10.1155/2022/6807203" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9159214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35685546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Clin%20Pract&amp;title=Epidemiological%20Trends%20of%20Urolithiasis%20at%20the%20Global,%20Regional,%20and%20National%20Levels:%20A%20Population-Based%20Study&amp;author=X%20Qian&amp;author=J%20Wan&amp;author=J%20Xu&amp;author=C%20Liu&amp;author=M%20Zhong&amp;volume=2022&amp;publication_year=2022&amp;pages=6807203&amp;pmid=35685546&amp;doi=10.1155/2022/6807203&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref022">
<span class="label">22.</span><cite>Jürgens V, Ess S, Cerny T, Vounatsou P. A Bayesian generalized age-period-cohort power model for cancer projections. Stat Med. 2014;33(26):4627–36. doi: 10.1002/sim.6248

</cite> [<a href="https://doi.org/10.1002/sim.6248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24996118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stat%20Med&amp;title=A%20Bayesian%20generalized%20age-period-cohort%20power%20model%20for%20cancer%20projections&amp;author=V%20J%C3%BCrgens&amp;author=S%20Ess&amp;author=T%20Cerny&amp;author=P%20Vounatsou&amp;volume=33&amp;issue=26&amp;publication_year=2014&amp;pages=4627-36&amp;pmid=24996118&amp;doi=10.1002/sim.6248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref023">
<span class="label">23.</span><cite>Liu Z, Xu K, Jiang Y, Cai N, Fan J, Mao X, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol. 2021;50(1):128–42. doi: 10.1093/ije/dyaa196

</cite> [<a href="https://doi.org/10.1093/ije/dyaa196" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33349860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Epidemiol&amp;title=Global%20trend%20of%20aetiology-based%20primary%20liver%20cancer%20incidence%20from%201990%20to%202030:%20a%20modelling%20study&amp;author=Z%20Liu&amp;author=K%20Xu&amp;author=Y%20Jiang&amp;author=N%20Cai&amp;author=J%20Fan&amp;volume=50&amp;issue=1&amp;publication_year=2021&amp;pages=128-42&amp;pmid=33349860&amp;doi=10.1093/ije/dyaa196&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref024">
<span class="label">24.</span><cite>Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties. J Hepatol. 2023;79(1):209–17. doi: 10.1016/j.jhep.2023.01.026

</cite> [<a href="https://doi.org/10.1016/j.jhep.2023.01.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10293095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36740046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=Healthcare%20and%20socioeconomic%20costs%20of%20NAFLD:%20A%20global%20framework%20to%20navigate%20the%20uncertainties&amp;author=AM%20Allen&amp;author=JV%20Lazarus&amp;author=ZM%20Younossi&amp;volume=79&amp;issue=1&amp;publication_year=2023&amp;pages=209-17&amp;pmid=36740046&amp;doi=10.1016/j.jhep.2023.01.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref025">
<span class="label">25.</span><cite>Younossi ZM, Tampi R, Priyadarshini M, Nader F, Younossi IM, Racila A. Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States. Hepatology. 2019;69(2):564–72. doi: 10.1002/hep.30254

</cite> [<a href="https://doi.org/10.1002/hep.30254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30180285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Burden%20of%20Illness%20and%20Economic%20Model%20for%20Patients%20With%20Nonalcoholic%20Steatohepatitis%20in%20the%20United%20States&amp;author=ZM%20Younossi&amp;author=R%20Tampi&amp;author=M%20Priyadarshini&amp;author=F%20Nader&amp;author=IM%20Younossi&amp;volume=69&amp;issue=2&amp;publication_year=2019&amp;pages=564-72&amp;pmid=30180285&amp;doi=10.1002/hep.30254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref026">
<span class="label">26.</span><cite>Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577–86. doi: 10.1002/hep.28785

</cite> [<a href="https://doi.org/10.1002/hep.28785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27543837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The%20economic%20and%20clinical%20burden%20of%20nonalcoholic%20fatty%20liver%20disease%20in%20the%20United%20States%20and%20Europe&amp;author=ZM%20Younossi&amp;author=D%20Blissett&amp;author=R%20Blissett&amp;author=L%20Henry&amp;author=M%20Stepanova&amp;volume=64&amp;issue=5&amp;publication_year=2016&amp;pages=1577-86&amp;pmid=27543837&amp;doi=10.1002/hep.28785&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref027">
<span class="label">27.</span><cite>Al-Daghri NM, Al-Saleh Y, Aljohani N, Alokail M, Al-Attas O, Alnaami AM, et al. Vitamin D Deficiency and Cardiometabolic Risks: A Juxtaposition of Arab Adolescents and Adults. PLoS One. 2015;10(7):e0131315. doi: 10.1371/journal.pone.0131315

</cite> [<a href="https://doi.org/10.1371/journal.pone.0131315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4506058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26186591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Vitamin%20D%20Deficiency%20and%20Cardiometabolic%20Risks:%20A%20Juxtaposition%20of%20Arab%20Adolescents%20and%20Adults&amp;author=NM%20Al-Daghri&amp;author=Y%20Al-Saleh&amp;author=N%20Aljohani&amp;author=M%20Alokail&amp;author=O%20Al-Attas&amp;volume=10&amp;issue=7&amp;publication_year=2015&amp;pmid=26186591&amp;doi=10.1371/journal.pone.0131315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref028">
<span class="label">28.</span><cite>Abul-Husn NS, Cheng X, Li AH, Xin Y, Schurmann C, Stevis P, et al. A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease. N Engl J Med. 2018;378(12):1096–106. doi: 10.1056/NEJMoa1712191

</cite> [<a href="https://doi.org/10.1056/NEJMoa1712191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6668033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29562163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20Protein-Truncating%20HSD17B13%20Variant%20and%20Protection%20from%20Chronic%20Liver%20Disease&amp;author=NS%20Abul-Husn&amp;author=X%20Cheng&amp;author=AH%20Li&amp;author=Y%20Xin&amp;author=C%20Schurmann&amp;volume=378&amp;issue=12&amp;publication_year=2018&amp;pages=1096-106&amp;pmid=29562163&amp;doi=10.1056/NEJMoa1712191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref029">
<span class="label">29.</span><cite>Rahim HFA, Sibai A, Khader Y, Hwalla N, Fadhil I, Alsiyabi H, et al. Non-communicable diseases in the Arab world. Lancet. 2014;383(9914):356–67. doi: 10.1016/S0140-6736(13)62383-1

</cite> [<a href="https://doi.org/10.1016/S0140-6736(13)62383-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24452044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Non-communicable%20diseases%20in%20the%20Arab%20world&amp;author=HFA%20Rahim&amp;author=A%20Sibai&amp;author=Y%20Khader&amp;author=N%20Hwalla&amp;author=I%20Fadhil&amp;volume=383&amp;issue=9914&amp;publication_year=2014&amp;pages=356-67&amp;pmid=24452044&amp;doi=10.1016/S0140-6736(13)62383-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref030">
<span class="label">30.</span><cite>Vilar-Gomez E, Nephew LD, Vuppalanchi R, Gawrieh S, Mladenovic A, Pike F, et al. High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology. 2022;75(6):1491–506. doi: 10.1002/hep.32207

</cite> [<a href="https://doi.org/10.1002/hep.32207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34668597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=High-quality%20diet,%20physical%20activity,%20and%20college%20education%20are%20associated%20with%20low%20risk%20of%20NAFLD%20among%20the%20US%20population&amp;author=E%20Vilar-Gomez&amp;author=LD%20Nephew&amp;author=R%20Vuppalanchi&amp;author=S%20Gawrieh&amp;author=A%20Mladenovic&amp;volume=75&amp;issue=6&amp;publication_year=2022&amp;pages=1491-506&amp;pmid=34668597&amp;doi=10.1002/hep.32207&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref031">
<span class="label">31.</span><cite>Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–37. doi: 10.1016/j.jhep.2023.03.017

</cite> [<a href="https://doi.org/10.1016/j.jhep.2023.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36990226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=Global%20burden%20of%20liver%20disease:%202023%20update&amp;author=H%20Devarbhavi&amp;author=SK%20Asrani&amp;author=JP%20Arab&amp;author=YA%20Nartey&amp;author=E%20Pose&amp;volume=79&amp;issue=2&amp;publication_year=2023&amp;pages=516-37&amp;pmid=36990226&amp;doi=10.1016/j.jhep.2023.03.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref032">
<span class="label">32.</span><cite>Ventura-Cots M, Bataller R, Lazarus JV, Benach J, Pericàs JM. Applying an equity lens to liver health and research in Europe. J Hepatol. 2022;77(6):1699–710. doi: 10.1016/j.jhep.2022.07.021

</cite> [<a href="https://doi.org/10.1016/j.jhep.2022.07.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35985542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=Applying%20an%20equity%20lens%20to%20liver%20health%20and%20research%20in%20Europe&amp;author=M%20Ventura-Cots&amp;author=R%20Bataller&amp;author=JV%20Lazarus&amp;author=J%20Benach&amp;author=JM%20Peric%C3%A0s&amp;volume=77&amp;issue=6&amp;publication_year=2022&amp;pages=1699-710&amp;pmid=35985542&amp;doi=10.1016/j.jhep.2022.07.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref033">
<span class="label">33.</span><cite>Della Torre S. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells. 2021;10(9):2502. doi: 10.3390/cells10092502

</cite> [<a href="https://doi.org/10.3390/cells10092502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8470830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34572151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Beyond%20the%20X%20Factor:%20Relevance%20of%20Sex%20Hormones%20in%20NAFLD%20Pathophysiology&amp;author=S%20Della%20Torre&amp;volume=10&amp;issue=9&amp;publication_year=2021&amp;pages=2502&amp;pmid=34572151&amp;doi=10.3390/cells10092502&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref034">
<span class="label">34.</span><cite>Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne). 2020;11:572490. doi: 10.3389/fendo.2020.572490

</cite> [<a href="https://doi.org/10.3389/fendo.2020.572490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7531579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33071979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Endocrinol%20(Lausanne)&amp;title=Non-alcoholic%20Fatty%20Liver%20Disease%20as%20a%20Canonical%20Example%20of%20Metabolic%20Inflammatory-Based%20Liver%20Disease%20Showing%20a%20Sex-Specific%20Prevalence:%20Relevance%20of%20Estrogen%20Signaling&amp;author=S%20Della%20Torre&amp;volume=11&amp;publication_year=2020&amp;pages=572490&amp;pmid=33071979&amp;doi=10.3389/fendo.2020.572490&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref035">
<span class="label">35.</span><cite>Meda C, Barone M, Mitro N, Lolli F, Pedretti S, Caruso D, et al. Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids. Mol Metab. 2020;32:97–108. doi: 10.1016/j.molmet.2019.12.009

</cite> [<a href="https://doi.org/10.1016/j.molmet.2019.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6957843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32029233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Metab&amp;title=Hepatic%20ER%CE%B1%20accounts%20for%20sex%20differences%20in%20the%20ability%20to%20cope%20with%20an%20excess%20of%20dietary%20lipids&amp;author=C%20Meda&amp;author=M%20Barone&amp;author=N%20Mitro&amp;author=F%20Lolli&amp;author=S%20Pedretti&amp;volume=32&amp;publication_year=2020&amp;pages=97-108&amp;pmid=32029233&amp;doi=10.1016/j.molmet.2019.12.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref036">
<span class="label">36.</span><cite>Maggi A, Della Torre S. Sex, metabolism and health. Mol Metab. 2018;15:3–7. doi: 10.1016/j.molmet.2018.02.012

</cite> [<a href="https://doi.org/10.1016/j.molmet.2018.02.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6066735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29550349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Metab&amp;title=Sex,%20metabolism%20and%20health&amp;author=A%20Maggi&amp;author=S%20Della%20Torre&amp;volume=15&amp;publication_year=2018&amp;pages=3-7&amp;pmid=29550349&amp;doi=10.1016/j.molmet.2018.02.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref037">
<span class="label">37.</span><cite>Della Torre S, Maggi A. Sex Differences: A Resultant of an Evolutionary Pressure?. Cell Metab. 2017;25(3):499–505. doi: 10.1016/j.cmet.2017.01.006

</cite> [<a href="https://doi.org/10.1016/j.cmet.2017.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28190772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metab&amp;title=Sex%20Differences:%20A%20Resultant%20of%20an%20Evolutionary%20Pressure?&amp;author=S%20Della%20Torre&amp;author=A%20Maggi&amp;volume=25&amp;issue=3&amp;publication_year=2017&amp;pages=499-505&amp;pmid=28190772&amp;doi=10.1016/j.cmet.2017.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref038">
<span class="label">38.</span><cite>Zou Y, Yu M, Sheng G. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids Health Dis. 2020;19(1):145. doi: 10.1186/s12944-020-01326-3

</cite> [<a href="https://doi.org/10.1186/s12944-020-01326-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7306139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32563249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lipids%20Health%20Dis&amp;title=Association%20between%20fasting%20plasma%20glucose%20and%20nonalcoholic%20fatty%20liver%20disease%20in%20a%20nonobese%20Chinese%20population%20with%20normal%20blood%20lipid%20levels:%20a%20prospective%20cohort%20study&amp;author=Y%20Zou&amp;author=M%20Yu&amp;author=G%20Sheng&amp;volume=19&amp;issue=1&amp;publication_year=2020&amp;pages=145&amp;pmid=32563249&amp;doi=10.1186/s12944-020-01326-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref039">
<span class="label">39.</span><cite>Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A. 2001;98(16):9116–21. doi: 10.1073/pnas.161284298

</cite> [<a href="https://doi.org/10.1073/pnas.161284298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC55382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11470916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=A%20glucose-responsive%20transcription%20factor%20that%20regulates%20carbohydrate%20metabolism%20in%20the%20liver&amp;author=H%20Yamashita&amp;author=M%20Takenoshita&amp;author=M%20Sakurai&amp;author=RK%20Bruick&amp;author=WJ%20Henzel&amp;volume=98&amp;issue=16&amp;publication_year=2001&amp;pages=9116-21&amp;pmid=11470916&amp;doi=10.1073/pnas.161284298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref040">
<span class="label">40.</span><cite>Chandrasekaran K, Swaminathan K, Chatterjee S, Dey A. Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro. 2010;24(2):387–96. doi: 10.1016/j.tiv.2009.10.020

</cite> [<a href="https://doi.org/10.1016/j.tiv.2009.10.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19892008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol%20In%20Vitro&amp;title=Apoptosis%20in%20HepG2%20cells%20exposed%20to%20high%20glucose&amp;author=K%20Chandrasekaran&amp;author=K%20Swaminathan&amp;author=S%20Chatterjee&amp;author=A%20Dey&amp;volume=24&amp;issue=2&amp;publication_year=2010&amp;pages=387-96&amp;pmid=19892008&amp;doi=10.1016/j.tiv.2009.10.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref041">
<span class="label">41.</span><cite>Mallat A, Lotersztajn S. Cigarette smoke exposure: a novel cofactor of NAFLD progression?
J Hepatol. 2009;51(3):430–2. doi: 10.1016/j.jhep.2009.05.021

</cite> [<a href="https://doi.org/10.1016/j.jhep.2009.05.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19596475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=Cigarette%20smoke%20exposure:%20a%20novel%20cofactor%20of%20NAFLD%20progression?&amp;author=A%20Mallat&amp;author=S%20Lotersztajn&amp;volume=51&amp;issue=3&amp;publication_year=2009&amp;pages=430-2&amp;pmid=19596475&amp;doi=10.1016/j.jhep.2009.05.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref042">
<span class="label">42.</span><cite>Lin C, Rountree CB, Methratta S, LaRusso S, Kunselman AR, Spanier AJ. Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children. Environ Res. 2014;132:264–8. doi: 10.1016/j.envres.2014.04.005

</cite> [<a href="https://doi.org/10.1016/j.envres.2014.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24834820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ%20Res&amp;title=Secondhand%20tobacco%20exposure%20is%20associated%20with%20nonalcoholic%20fatty%20liver%20disease%20in%20children&amp;author=C%20Lin&amp;author=CB%20Rountree&amp;author=S%20Methratta&amp;author=S%20LaRusso&amp;author=AR%20Kunselman&amp;volume=132&amp;publication_year=2014&amp;pages=264-8&amp;pmid=24834820&amp;doi=10.1016/j.envres.2014.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref043">
<span class="label">43.</span><cite>Liu E, Li Q, Pan T, Chen Y. Association Between Secondhand Smoke Exposure and Nonalcoholic Fatty Liver Disease in the General U.S. Adult Nonsmoker Population. Nicotine Tob Res. 2024;26(6):663–8. doi: 10.1093/ntr/ntad249

</cite> [<a href="https://doi.org/10.1093/ntr/ntad249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38124389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nicotine%20Tob%20Res&amp;title=Association%20Between%20Secondhand%20Smoke%20Exposure%20and%20Nonalcoholic%20Fatty%20Liver%20Disease%20in%20the%20General%20U.S.%20Adult%20Nonsmoker%20Population&amp;author=E%20Liu&amp;author=Q%20Li&amp;author=T%20Pan&amp;author=Y%20Chen&amp;volume=26&amp;issue=6&amp;publication_year=2024&amp;pages=663-8&amp;pmid=38124389&amp;doi=10.1093/ntr/ntad249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330504.ref044">
<span class="label">44.</span><cite>Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?. J Hepatol. 2022;76(4):771–80. doi: 10.1016/j.jhep.2021.10.025

</cite> [<a href="https://doi.org/10.1016/j.jhep.2021.10.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34895743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=The%20global%20NAFLD%20policy%20review%20and%20preparedness%20index:%20Are%20countries%20ready%20to%20address%20this%20silent%20public%20health%20challenge?&amp;author=JV%20Lazarus&amp;author=HE%20Mark&amp;author=M%20Villota-Rivas&amp;author=A%20Palayew&amp;author=P%20Carrieri&amp;volume=76&amp;issue=4&amp;publication_year=2022&amp;pages=771-80&amp;pmid=34895743&amp;doi=10.1016/j.jhep.2021.10.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0330504.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330504.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330504.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Hamidreza Karimi-Sari</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Hamidreza Karimi-Sari</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamidreza Karimi-Sari</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hamidreza Karimi-Sari</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Hamidreza Karimi-Sari</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>27 May 2025</em>
</p>
<p>Dear Dr. Wang,</p>
<p>Please submit your revised manuscript by Jul 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Hamidreza Karimi-Sari</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a> .</p>
<p>2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files]</p>
<p>Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (<a href="https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition</a>).</p>
<p>For example, authors should submit the following data:</p>
<p>- The values behind the means, standard deviations and other measures reported;</p>
<p>- The values used to build graphs;</p>
<p>- The points extracted from images for analysis.</p>
<p>Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.</p>
<p>If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see <a href="https://journals.plos.org/plosone/s/recommended-repositories" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/recommended-repositories</a>.</p>
<p>If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.</p>
<p>3. We note that Figures 1 &amp; 2 your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: <a href="http://journals.plos.org/plosone/s/licenses-and-copyright" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://journals.plos.org/plosone/s/licenses-and-copyright</a>.</p>
<p>We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:</p>
<p>a. You may seek permission from the original copyright holder of Figures 1 &amp; 2 to publish the content specifically under the CC BY 4.0 license. </p>
<p>We recommend that you contact the original copyright holder with the Content Permission Form (<a href="http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf</a>) and the following text:</p>
<p>“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (<a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”</p>
<p>Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.</p>
<p>In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”</p>
<p> b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.</p>
<p>The following resources for replacing copyrighted map figures may be helpful:</p>
<p>USGS National Map Viewer (public domain): <a href="http://viewer.nationalmap.gov/viewer/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://viewer.nationalmap.gov/viewer/</a></p>
<p>The Gateway to Astronaut Photography of Earth (public domain): <a href="http://eol.jsc.nasa.gov/sseop/clickmap/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://eol.jsc.nasa.gov/sseop/clickmap/</a></p>
<p>Maps at the CIA (public domain): <a href="https://www.cia.gov/library/publications/the-world-factbook/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cia.gov/library/publications/the-world-factbook/index.html</a> and <a href="https://www.cia.gov/library/publications/cia-maps-publications/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cia.gov/library/publications/cia-maps-publications/index.html</a></p>
<p>NASA Earth Observatory (public domain): <a href="http://earthobservatory.nasa.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://earthobservatory.nasa.gov/</a></p>
<p>Landsat: <a href="http://landsat.visibleearth.nasa.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://landsat.visibleearth.nasa.gov/</a></p>
<p>USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): <a href="http://eros.usgs.gov/#" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://eros.usgs.gov/#</a></p>
<p>Natural Earth (public domain): <a href="http://www.naturalearthdata.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.naturalearthdata.com/</a></p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>Reviewer #1: Partly</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? --&gt;?&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available??&gt;</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a></p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>Reviewer #1: The authors assessed the global burden of NAFLD from 1990 to 2021 encompassing 204 countries, 21 regions with varying disease burdens, and 5 SDI areas. Projections of global burden trends were made using a Bayesian age-period-cohort (BAPC) model. The study provides informative summaries of increasing NAFLD burden overall and national level. My questions below are related to projection, estimation of association between risk factors and NAFLD burden, and their interpretations which needs further clarification.</p>
<p>The authors used BAPC models to estimate reasonable predictions of global burden trends. Additional details would help understand the approach. What prior was used? Has sensitivity analysis done based on the different choices of priors? The authors also mention the prediction yields precise predictions of ASIR, ASPR, and ASMR (line 287). Please elaborate on the reliability and robustness of the predictions.</p>
<p>From Figure 3, high SDI group has the lowest incidence and prevalence of NAFLD, but all other groups have wide overlap. How is the uncertainty represented by the ribbons around the estimates captured here? Are these model-based confidence intervals? If not, have the authors considered fitting a model to test whether middle SDI has the highest and high SDI has the lowest ASIR and ASPR trends over time?</p>
<p>Why is there such a big gap of ASIR and ASPR trends between high SDI vs. other SDI? Do the authors have hypothesis driving this?</p>
<p>The authors used SDI calculated from several social factors, including the fertility rate of the population aged &lt;25 years, the education level of the population aged &gt;15 years, and per capita income. Have the authors investigated the association of these individual factors to NAFLD burden?</p>
<p>The risk factors were assessed at country and regional levels. Were data available on a more granular level? If not, would the authors see this as a limitation to the study?</p>
<p>The inverted U-shaped relationship depicted in the figures seems to be heavily influenced by the outlier regions. I suggest removing the smoothed lines unless they are model based. Can the authors elaborate on the effects beyond SDI that may influence these outliers (North Africa and Middle East has the highest prevalence and incidence and Central and Andean Latin America have highest death rate and DALYs)?</p>
<p>Minor points</p>
<p>Abstract Results line 32 &amp; Results line 129: it is unclear what “this age group” refers to.</p>
<p>Abstract Results line 35: SDI needs to be defined.</p>
<p>The fonts of texts and legends in figures 4 and 5 should be increased.</p>
<p>**********</p>
<p><a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a></p>
<p>Reviewer #1: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0330504.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 22;20(8):e0330504. doi: <a href="https://doi.org/10.1371/journal.pone.0330504.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330504.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>9 Jul 2025</em>
</p>
<p>Response to reviewers’ comments</p>
<p>Journal Requirements: #1-1: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>.</p>
<p>Response: Thanks. We confirm that we have carefully reviewed and strictly adhered to all PLOS ONE style guidelines as outlined in the provided templates and author instructions. Should you require any additional clarification or specific file verification, please do not hesitate to let us know.</p>
<p>Journal Requirements: #1-2: We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files]</p>
<p>Response: Thank you for the reminder. In this revision, we have included all the raw data required to replicate the results of the study. The relevant information has been added to the main text and supplementary materials.</p>
<p>Journal Requirements: #1-3: We note that Figures 1 &amp; 2 your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth).</p>
<p>Response: Response: Thank you for raising questions regarding the map images in Figure 1 and 2. Please find our responses below:</p>
<p>a) Source of Map Images:</p>
<p>The map images in Figure 1 and 2 were created using the rnaturalearth R package, which provides access to Natural Earth map data. This data is open-source and available at <a href="https://github.com/ropensci/rnaturalearth" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/ropensci/rnaturalearth</a>.</p>
<p>b) Copyright Status:</p>
<p>To our knowledge, the map data from Natural Earth provided through the rnaturalearth package is in the public domain and therefore not subject to copyright restrictions. Natural Earth map data is widely used for world mapping and is explicitly designed for open, unrestricted use.</p>
<p>c) Permission for Use:</p>
<p>Since the map images derive from open-source public domain data provided by Natural Earth, we believe no additional copyright permission is required. However, if necessary, we can include a statement attributing Natural Earth as the data source.</p>
<p>Reviewer #1: The authors assessed the global burden of NAFLD from 1990 to 2021 encompassing 204 countries, 21 regions with varying disease burdens, and 5 SDI areas. Projections of global burden trends were made using a Bayesian age-period-cohort (BAPC) model. The study provides informative summaries of increasing NAFLD burden overall and national level. My questions below are related to projection, estimation of association between risk factors and NAFLD burden, and their interpretations which needs further clarification.</p>
<p>Response: We sincerely thank for their thoughtful evaluation of our work and their recognition of the study's global scope and methodological approach.</p>
<p>Reviewer #1-1: The authors used BAPC models to estimate reasonable predictions of global burden trends. Additional details would help understand the approach. What prior was used? Has sensitivity analysis done based on the different choices of priors? The authors also mention the prediction yields precise predictions of ASIR, ASPR, and ASMR (line 287). Please elaborate on the reliability and robustness of the predictions.</p>
<p>Response: Thank you for your valuable suggestion. Because of the relatively lower absolute percentage deviation for the BAPC model, we used it for the projections of NAFLD incidence rates and case numbers through 2035.</p>
<p>The APC model assumes there is a multiplicative effect of age, period and cohort,</p>
<p>Y_ap=μ'〖α'〗_a 〖β'〗_p 〖γ'〗_c,</p>
<p>Where Y_ap denotes the incident case counts, 〖α'〗_adenotes the age effect, 〖β'〗_p denotes the period effect and〖 γ'〗_cdenotes the cohort effect. Where μ, α_a⁠, β_p and γ_c are the logarithms of μ'⁠, 〖α'〗_a, 〖β'〗_p and 〖γ'〗_c⁠, respectively.</p>
<p>We conducted a BAPC analysis with integrated nested Laplace approximation (INLA). To ensure smoothing, BAPC models assume independent mean-zero normal distributions on the second differences of all effects. Specifically, the BAPC model assumes prior distribution of the age effect as follows:</p>
<p>f(α│k_α )∝k_α^((t-2)/2) exp⁡{-k_α/2 ∑_(i=3)^I▒[(α_i-α_(i-1) )-(α_(i-1)-α_(i-2) )]^2 },</p>
<p>Considering that we are interested in the incident case counts for age group a, with a t period into the future, the following equation can be applied:</p>
<p>〖log⁡(Y〗_(a,p+t))=〖μ+α〗_a+β_(p+t)+γ_(c+t)+δ_(a,p+t),</p>
<p>Here, we add an independent random effect δ_(a,p+t)∼N(0,k_δ^(-1) ) to adjust for overdispersion. Considering the smoothing assumption, the BAPC models assume prior distribution of the period effect as follows:</p>
<p>β_(p+t) |β_1 〖,…,β〗_p,k_β∼N((1+t)β_p-tβ_(p-1),k_β^(-1) (1+2^2+⋯+t^2)),</p>
<p>The summary estimates (mean, standard deviation, 2.5% quantile, median and 97.5% quantile) of all variance parameters in the BAPC models can be obtained. (PMID: 33349860) To evaluate the reliability and robustness of these predictions, we compared the mean values and 95% UI predicted by the BAPC model from 1990 to 2021 with the actual values. The predicted values were within the 95% UI of the actual values, thereby confirming the reliability and robustness of the model. For example, in 1990, the ASIR in the global was 477.04 (95% UI: 476.85–477.23) predicted by BAPC models (S7 Table), and the actual value, it was 475.54 (95% UI: 432.59-518.19) (Table 1).</p>
<p>Reviewer #1-2: From Figure 3, high SDI group has the lowest incidence and prevalence of NAFLD, but all other groups have wide overlap. How is the uncertainty represented by the ribbons around the estimates captured here? Are these model-based confidence intervals? If not, have the authors considered fitting a model to test whether middle SDI has the highest and high SDI has the lowest ASIR and ASPR trends over time?</p>
<p>Response: Thank you for your valuable suggestion. The ribbons in Figure 3 represent the 95% uncertainty intervals (UIs), which are based on DisMod model used in the GBD study. It is used to reflect the estimated values of incidence or DALYs of SDI in different regions in a certain year, as well as the uncertain intervals. For example, in 1990, the ASIR for the middle SDI group was 534 (95% UI: 485–581), and for the low-middle SDI group, it was 521 (95% UI: 474–568). Although the ASIR of the middle SDI group is estimated to be higher than that of the low-middle SDI group, due to the overlap of the 95% UI, the difference cannot be considered statistically significant. In addition, regarding the trend of SDI groups changing over the years, we have analyzed it through the estimated annual percentage change (EAPC). The results are shown in Table 1-4 to present the changing trends of different SDI groups during the study period.</p>
<p>Reviewer #1-3: Why is there such a big gap of ASIR and ASPR trends between high SDI vs. other SDI? Do the authors have hypothesis driving this?</p>
<p>Response: Thanks for the question. We propose the inverted U-shaped relationship between SDI and NAFLD burden (peak in middle SDI, lowest in high SDI) arises from intersecting epidemiological transitions and healthcare disparities: 1) Middle SDI regions experience rapid urbanization-driven dietary shifts and sedentary lifestyles, outpacing preventive healthcare capacity, creating unchecked obesogenic environments; 2) Importantly, the incidence and prevalence of NAFLD are relatively low in high SDI regions, which can be attributed to the effective public health measures and the population's higher health awareness. Nationwide NAFLD screening in countries enables early intervention. Furthermore, high SDI regions often have policies and regulations in place that promote healthier environments. This can include initiatives to reduce the availability and consumption of unhealthy foods, as well as promoting physical activity through urban planning and public health campaigns. 3) The relatively high EAPC in high-SDI regions paradoxically reflects their advanced healthcare capacity: expanded non-invasive screening captures subclinical NAFLD cases that would remain undetected in resource-limited settings, while aging populations manifest prevalence peaks (75-79y). Residual heterogeneity may reflect unmeasured genetic/environmental factors, warranting future granular studies.(PMID: 34668658, 39980749)</p>
<p>Reviewer #1-4: The authors used SDI calculated from several social factors, including the fertility rate of the population aged &lt;25 years, the education level of the population aged &gt;15 years, and per capita income. Have the authors investigated the association of these individual factors to NAFLD burden?</p>
<p>Response: Thanks for raising this important point. We thank the reviewer for raising this important point regarding the potential independent associations between individual SDI components—including adolescent fertility rates, population education levels, and per capita income—and NAFLD burden. While our current study utilized the composite SDI metric as an integrated indicator of socioeconomic development (following GBD methodology), we acknowledge that examining these constituent factors separately could yield deeper insights. Emerging evidence suggests distinct pathways: lower educational attainment may constrain health literacy and preventive behaviors; income disparities likely create differential access to nutritious diets and healthcare; while high adolescent fertility could induce metabolic stressors during critical developmental periods. Although our aggregated approach precluded granular analysis of these relationships, we recognize their significance and will address this limitation in the revised Discussion.</p>
<p>Reviewer #1-5: The risk factors were assessed at country and regional levels. Were data available on a more granular level? If not, would the authors see this as a limitation to the study?</p>
<p>Response: Thank you for your valuable suggestion. This study relies on the GBD 2021 dataset, risk factors cannot obtain data on a more granular level. We acknowledge this as a limitation of our study and have explained it in the discussion section ‘Secondly, as the research is based on the GBD 2021 database, currently only risk factor estimates at the national and regional levels are provided, and it is still impossible to conduct analyses at a finer granularity (such as provincial or city-level). Therefore, we are unable to assess the differences in risk factor exposure among different regions within a country, which to some extent limits the application of the results in local public health decision-making’.</p>
<p>Reviewer #1-6: The inverted U-shaped relationship depicted in the figures seems to be heavily influenced by the outlier regions. I suggest removing the smoothed lines unless they are model based. Can the authors elaborate on the effects beyond SDI that may influence these outliers (North Africa and Middle East has the highest prevalence and incidence and Central and Andean Latin America have highest death rate and DALYs)?</p>
<p>Response: Thank you for your valuable suggestion. In response, we have re-analyzed the data after removing the identified outlier regions and re-plotted the figure as follows. The results show that the inverted U-shaped relationship remains evident, suggesting that this trend is robust and not solely driven by outliers.</p>
<p>We attribute the exceptional NAFLD burden in North Africa/Middle East (ASPR: 27,686.69/100,000; ASIR: 1,037.64/100,000) and high mortality in Central/Andean Latin America (ASMR: 5.89/100,000; ASDR: 142.16/100,000) to region-specific amplifiers beyond SDI. In North Africa/Middle East, genetic susceptibility synergizes with rapid dietary transitions toward sugar-sweetened beverages and saturated fats, while endemic vitamin D deficiency (&gt;80% prevalence) exacerbates insulin resistance (PMID: 26186591, 24452044). Conversely, Latin America's mortality burden stems from healthcare fragmentation—delayed diagnosis due to limited advanced diagnostics (e.g., FibroScan scarcity) and restricted transplant access—compounded by competing social risks (e.g., violence-related trauma) and dual epidemics of NAFLD with chronic viral hepatitis/H. pylori infections that accelerate liver damage (PMID: 36990226). These factors create distinct pathogenic landscapes where genetic-epigenetic interactions amplify incidence in one region, and systemic healthcare gaps convert prevalence to mortality in another. We incorporated this point into the Discussion section of the revised manuscript.</p>
<p>Reviewer #1-7: Abstract Results line 32 &amp; Results line 129: it is unclear what “this age group” refers to.</p>
<p>Response: Thank you for pointing out the ambiguity. “This age group” refers to the all-age population. We have revised in the manuscript.</p>
<p>Reviewer #1-8: Abstract Results line 35: SDI needs to be defined.</p>
<p>Response: Thank you for your valuable suggestion. We have defined SDI to Socio-demographic index in Abstract Results line 35.</p>
<p>Reviewer #1-9: The fonts of texts and legends in figures 4 and 5 should be increased.</p>
<p>Response: Thank you for your valuable suggestion. We have revised figure 4 and 5 accordingly based on your comment.</p>
<section class="sm xbox font-sm" id="pone.0330504.s009"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers Comments 20250709.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s009.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s009.docx</a><sup> (434.6KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0330504.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330504.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330504.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Hamidreza Karimi-Sari</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Hamidreza Karimi-Sari</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamidreza Karimi-Sari</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hamidreza Karimi-Sari</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Hamidreza Karimi-Sari</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>4 Aug 2025</em>
</p>
<p>Global burden of NAFLD 1990-2021 and projections to 2035: results from the global burden of disease study 2021</p>
<p>PONE-D-24-57511R1</p>
<p>Dear Dr. Wang,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact <a href="https://plos.my.site.com/s/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">billing support</a> .</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Hamidreza Karimi-Sari</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>Reviewer #1: All comments have been addressed</p>
<p>Reviewer #2: (No Response)</p>
<p>**********</p>
<p>2. Is the manuscript technically sound, and do the data support the conclusions??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Has the statistical analysis been performed appropriately and rigorously? --&gt;?&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Have the authors made all data underlying the findings in their manuscript fully available??&gt;</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>Reviewer #1: I would like to thank the authors for thoroughly addressing all my comments. I believe the manuscript has greater clarity and have no further questions.</p>
<p>Reviewer #2: Thank you to the authors for their thorough responses to the feedback and efforts to address them. I commend the authors for this rigorous, impactful and novel research. Its findings have important implications in addressing NAFLD worldwide. I just have minor comments:</p>
<p>Abstract: The abstract was well-written. I have a few suggestions: 1) Add predicting the projection of NAFLD in the aims sentence (“This study used...”). 2) Remove repetition in the Background and Methods. For example, the time period was repeated three times and the data source twice. 3) Briefly introduce the socio-demographic index and its source.</p>
<p>Figures/Tables: As mentioned by a previous reviewer, it remains unclear what the ribbons in Figure 3 represent based on the figure alone. It could be informative to add 95% UI and 95% CI in the legendary or a footnote. Similarly, Tables 1 and 2 specify either 95% UI or 95% CI for ASPR and EAPC, but not incident or prevalent cases. What do the intervals for these mean? I couldn’t find it in the methods.</p>
<p>Results: There was a tendency in some subsections, such as Age and sex patterns and Risk factors attributable to NAFLD burden, to interpret the results in the Results rather than the Discussion. For example, the authors wrote in lines 194-196: “...which may mean that younger men are more likely to develop NAFLD.” Additionally, in lines 213-214: “These suggested the importance of fasting plasma glucose management for NAFLD control (Fig 6A, 6B).” The Results section should report findings objectively, while interpretation of findings be reported in the Discussion.</p>
<p>Overall, I commend the authors for their wonderful work. I look forward to seeing the research through.</p>
<p>**********</p>
<p><a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a></p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0330504.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330504.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330504.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Hamidreza Karimi-Sari</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Hamidreza Karimi-Sari</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karimi-Sari%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hamidreza Karimi-Sari</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.f" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.f" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hamidreza Karimi-Sari</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.f" class="d-panel p" style="display: none">
<div>© 2025 Hamidreza Karimi-Sari</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-24-57511R1</p>
<p>PLOS ONE</p>
<p>Dear Dr. Wang,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Hamidreza Karimi-Sari</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Table. ASIR, ASPR, ASMR, ASDR of NAFLD for both sexes in 204 countries and territories in 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s001.xlsx</a><sup> (67.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Table. EAPC of the ASIR, ASPR, ASMR, ASDR for both sexes in NAFLD in 204 countries and territories from 1990–2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s002.xlsx</a><sup> (34.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 Table. ASIR, ASPR, ASMR, ASDR trends in global disease burden of NAFLD at different SDI levels from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s003.xlsx</a><sup> (54.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S4 Table. ASIR, ASPR, ASMR, ASDR of NAFLD among regions based on SDI from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s004.xlsx</a><sup> (181.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S5 Table. Global disease burden of NAFLD in males and females by different age group in 2021.</span><p>Incidence cases and ASIR; prevalence cases and ASPR; death cases and ASMR; DALYs and ASDR.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s005.xlsx</a><sup> (34.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>S6 Table. The proportion of deaths and DALYs attributed to risk factors of NAFLD from 1990 to 2021.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s006.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s006.xlsx</a><sup> (37.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p">
<span>S7 Table. Trends in the NAFLD-related ASIR, ASPR, ASMR in the global (BAPC models).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s007.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s007.xlsx</a><sup> (20.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers Comments 20250709.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373163/bin/pone.0330504.s009.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330504.s009.docx</a><sup> (434.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The datasets for this article are available from the Global Health Data Exchange query tool (<a href="http://ghdx.healthdata.org/gbd-results-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://ghdx.healthdata.org/gbd-results-tool</a>).</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330504"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330504.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373163/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373163/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373163%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373163/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373163/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373163/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40845036/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373163/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40845036/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373163/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373163/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="FRDX11VQW84Hp0iAoXhRfh831jxcxj7NLoi9wXSItG3W5VCh7L1eSnN7g5jGrOlV">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
